Data / Research funding / Genetic Testing
Genetic Testing: 621 NIH awards ($951.7M) to 199 organizations
621 NIH awards ($951.7M) in the NIH spending category Genetic Testing, to 199 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 621 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Color's software-powered, high-touch delivery of genetic counseling sessions and pharmacogenomics consultations for return of genomic results | NIH | Office of the Director, National Institutes of Health | 2021 to 2023 | $39,709,604 | August 20, 2019 | September 19, 2024 | TOPPER, SCOTT | reporter.nih.gov |
| Color's software and services platform for the Return of Personalized Value to the All of Us Research Program participants | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $21,181,689 | September 20, 2024 | January 31, 2026 | TOPPER, SCOTT | reporter.nih.gov |
| Frontotemporal Dementia: Genes, Images, and Emotions | NIH | National Institute on Aging | 2021 to 2025 | $20,694,825 | September 1, 2002 | April 30, 2028 | GORNO TEMPINI, MARIA LUISA | reporter.nih.gov |
| Alzheimer's Prevention Initiative ADAD Colombia Trial Program | NIH | National Institute on Aging | 2024 to 2025 | $20,406,409 | September 1, 2024 | August 31, 2029 | ALEXANDER, ROBERT C | reporter.nih.gov |
| Feasibility of Genomic Newborn Screening Through Public Health Laboratories | NIH | Office of the Director, National Institutes of Health | 2025 | $14,399,393 | September 15, 2025 | September 14, 2028 | GREEN, ROBERT C. | reporter.nih.gov |
| Stanford Mendelian Genomics Research Center | NIH | National Human Genome Research Institute | 2021 to 2025 | $14,229,424 | July 15, 2021 | April 30, 2027 | MONTGOMERY, STEPHEN | reporter.nih.gov |
| Impacts of receiving Alzheimer's disease genetic risk information among Latinos in northern Manhattan | NIH | National Institute on Aging | 2021 to 2024 | $12,295,034 | February 15, 2020 | November 30, 2025 | OTTMAN, RUTH | reporter.nih.gov |
| Prospective Genetic Risk Evaluation and Assessment (PROGRESS) in Autism | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $9,460,610 | September 6, 2022 | August 31, 2027 | VEENSTRA-VANDERWEELE, JEREMY | reporter.nih.gov |
| The Center for Actionable Variant Analysis; measuring variant function at scale | NIH | National Human Genome Research Institute | 2021 to 2025 | $8,288,018 | August 23, 2021 | May 31, 2026 | STARITA, LEA | reporter.nih.gov |
| Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $6,609,782 | September 30, 2014 | August 31, 2030 | BENATAR, MICHAEL | reporter.nih.gov |
| NEWBORN SCREENING TRANSLATIONAL RESEARCH NETWORK (NBSTRN). | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $6,244,067 | September 26, 2018 | March 25, 2024 | BROWER, AMY | reporter.nih.gov |
| NEWBORN SCREENING PILOT STUDY FOR METACHROMATIC LEUKODYSTROPHY (MLD) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $5,899,672 | September 26, 2024 | September 25, 2026 | CAGGANA, MICHELLE | reporter.nih.gov |
| Clinical Genetics and Screening for Pulmonary Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,442,199 | January 1, 2016 | November 30, 2026 | HUNNINGHAKE, GARY MATTHEW | reporter.nih.gov |
| IGNITE EP2 - Admin Supplement | NIH | National Human Genome Research Institute | 2021 to 2024 | $5,199,656 | July 1, 2024 | June 30, 2025 | CAVALLARI, LARISA HUMMA | reporter.nih.gov |
| Precision approaches to refining TP53-associated cancer risk | NIH | National Cancer Institute | 2021 to 2023 | $5,115,949 | September 18, 2019 | August 31, 2025 | GRUBER, STEPHEN B | reporter.nih.gov |
| Genomic medicine and gene function implementation for an underserved population | NIH | National Human Genome Research Institute | 2021 to 2025 | $4,796,292 | July 13, 2021 | April 30, 2027 | BELLEN, HUGO J | reporter.nih.gov |
| Prenatal Genetic Diagnosis by Genomic Sequencing: A Prospective Evaluation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $4,717,401 | August 4, 2025 | July 31, 2029 | WAPNER, RONALD | reporter.nih.gov |
| Real-time genetic diagnosis at the point of care | NIH | National Human Genome Research Institute | 2021 to 2025 | $4,619,886 | August 10, 2021 | August 31, 2026 | WILLIAMS, MARC S. | reporter.nih.gov |
| BUILDING THE EVIDENCE BASE FOR APPROPRIATE AND EFFICIENT IMPLEMENTATION OF EMERGING GENOMIC TESTS FOR DISEASE MANAGEMENT AND SCREENING | NIH | National Human Genome Research Institute | 2021 to 2025 | $4,599,158 | July 8, 2021 | April 30, 2027 | PHILLIPS, KATHRYN A | reporter.nih.gov |
| Clinical Implementation Resources for Pharmacogenomics (CIRP) | NIH | National Human Genome Research Institute | 2023 to 2025 | $4,439,999 | September 8, 2023 | June 30, 2027 | KLEIN, TERI ELLEN | reporter.nih.gov |
| Genetic Susceptibility and Biomarkers of Platinum-related Toxicities | NIH | National Cancer Institute | 2021 to 2025 | $4,370,186 | September 25, 2012 | June 30, 2027 | TRAVIS, LOIS B. | reporter.nih.gov |
| SCAN-MP (Screening for Cardiac Amyloidosiswith Nuclear imaging in Minority Populations) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $4,328,776 | May 1, 2019 | February 28, 2025 | MAURER, MATHEW S | reporter.nih.gov |
| Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $4,228,325 | May 1, 2019 | March 31, 2025 | SAUNDERS-PULLMAN, RACHEL | reporter.nih.gov |
| Probing Phenotype-Genotype Relations After Whole Genome Sequencing in Patients with Atrial Fibrillation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,058,145 | September 1, 2021 | July 31, 2026 | SHOEMAKER, MOORE BENJAMIN | reporter.nih.gov |
| Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma | NIH | National Cancer Institute | 2021 to 2025 | $3,998,452 | May 17, 2016 | March 31, 2028 | BRAND, RANDALL | reporter.nih.gov |
| Resolving the cancer relevance of predisposition gene mutations | NIH | National Cancer Institute | 2021 to 2025 | $3,942,823 | September 1, 2020 | August 31, 2027 | COUCH, FERGUS JOSEPH | reporter.nih.gov |
| Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation | NIH | National Cancer Institute | 2022 to 2025 | $3,855,091 | September 22, 2022 | August 31, 2027 | MARKOWITZ, SANFORD D. | reporter.nih.gov |
| Calypso: a web software system supporting team-based, longitudinal genomic diagnostic care | NIH | National Human Genome Research Institute | 2022 to 2025 | $3,835,244 | February 1, 2022 | January 31, 2027 | MARTH, GABOR T | reporter.nih.gov |
| Resilience to Cognitive Decline and Resistance to Alzheimer's Disease and Related Neurodegenerative Diseases in Individuals from Colombia with Autosomal Dominant Dementias | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $3,821,618 | August 15, 2023 | July 31, 2026 | QUIROZ, YAKEEL T. | reporter.nih.gov |
| Systems Biology of Bone Marrow Failure and MDS for Precision Medicine | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $3,813,084 | September 15, 2019 | June 30, 2024 | SHIMAMURA, AKIKO | reporter.nih.gov |
| Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,767,699 | July 15, 2016 | August 31, 2027 | MAJUMDER, SHOUNAK | reporter.nih.gov |
| Deploying a genomic-medicine risk assessment model for primary care populations | NIH | National Human Genome Research Institute | 2021 to 2025 | $3,726,690 | August 17, 2021 | December 31, 2026 | HAGA, SUSANNE | reporter.nih.gov |
| Estimating the risk for and severity of respiratory infections attributable to CFTR heterozygosity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,719,716 | April 1, 2021 | March 31, 2027 | POLGREEN, PHILIP M | reporter.nih.gov |
| The Funding Mechanism of the Pilot Trial | NIH | National Cancer Institute | 2023 to 2025 | $3,690,580 | August 11, 2023 | July 31, 2028 | OLOPADE, OLUFUNMILAYO F. | reporter.nih.gov |
| RESPECT3: A Randomized type 1 hybrid Effectiveness-implementation Study of returning actionable genetic PanEl researCh resulTs | NIH | National Cancer Institute | 2021 to 2025 | $3,683,188 | September 9, 2014 | May 31, 2026 | BRADBURY, ANGELA R. | reporter.nih.gov |
| Blood-Based Testing for Advanced Adenoma | NIH | National Cancer Institute | 2022 to 2025 | $3,665,539 | September 12, 2022 | February 29, 2028 | SCHOEN, ROBERT E. | reporter.nih.gov |
| Genetic Predictors of Prostate Cancer Survival | NIH | National Cancer Institute | 2021 to 2025 | $3,655,797 | January 15, 2021 | December 31, 2026 | KLEIN, ROBERT J. | reporter.nih.gov |
| Using markers to improve pancreatic cancer screening and surveillance: a multi-center study | NIH | National Cancer Institute | 2021 to 2025 | $3,641,472 | July 18, 2016 | August 31, 2027 | GOGGINS, MICHAEL G. | reporter.nih.gov |
| Rare Mutations and Autism Spectrum Disorders | NIH | National Institute of Mental Health | 2021 to 2025 | $3,601,036 | August 1, 2013 | October 31, 2026 | EICHLER, EVAN | reporter.nih.gov |
| Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana. | NIH | National Human Genome Research Institute | 2021 to 2024 | $3,584,747 | September 19, 2018 | June 30, 2025 | SKAAR, TODD C. | reporter.nih.gov |
| Clinical Diagnostic Sequencing of Structural Variation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,579,081 | April 1, 2015 | August 31, 2026 | TALKOWSKI, MICHAEL E | reporter.nih.gov |
| Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids | NIH | National Cancer Institute | 2021 to 2025 | $3,568,891 | September 19, 2018 | August 31, 2028 | PAPADOPOULOS, NICKOLAS | reporter.nih.gov |
| Increasing the Yield and Utility of Pediatric Genomic Medicine with Exomiser | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,566,476 | April 10, 2021 | June 14, 2026 | ROBINSON, PETER NICHOLAS | reporter.nih.gov |
| Translating the Clinical Knowledge of Mendelian Diseases to Real-world EHR Data to Improve Identification of Undiagnosed Patients | NIH | National Human Genome Research Institute | 2022 to 2025 | $3,533,176 | September 15, 2022 | June 30, 2027 | BASTARACHE, LISA | reporter.nih.gov |
| Mosaic: post-zygotic mutations in vascular malformations | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,511,307 | February 8, 2016 | June 30, 2025 | BENNETT, JAMES T | reporter.nih.gov |
| Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial Network | NIH | National Human Genome Research Institute | 2021 to 2024 | $3,458,289 | July 1, 2024 | June 30, 2025 | PETERSON, JOSEPH F. | reporter.nih.gov |
| Digital Technology to Enhance Access to and Effectiveness of Cancer Genetic Counseling | NIH | National Human Genome Research Institute | 2022 to 2025 | $3,456,199 | August 15, 2022 | May 31, 2027 | OFFIT, KENNETH | reporter.nih.gov |
| Using Behavioral Economics and Implementation Science to Advance the Use of Genomic Medicine Utilizing an EHR Infrastructure across a Diverse Health System | NIH | National Human Genome Research Institute | 2022 to 2025 | $3,403,942 | September 9, 2022 | June 30, 2027 | NATHANSON, KATHERINE L. | reporter.nih.gov |
| UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center | NIH | National Cancer Institute | 2021 to 2025 | $3,358,438 | March 13, 2019 | February 28, 2026 | MERKER, JASON DEREK | reporter.nih.gov |
| NY ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,337,243 | September 4, 2012 | August 31, 2029 | WASSERSTEIN, MELISSA PITTEL | reporter.nih.gov |
| Integrating a culturally competent APOL1 genetic testing program into living donor evaluation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,312,983 | April 1, 2021 | March 31, 2027 | AGRAWAL, AKANSHA | reporter.nih.gov |
| Strategy for combining circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) measures of tumor burden for prediction of response and outcome in neoadjuvant-treated early breast cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,290,798 | December 3, 2020 | November 30, 2026 | VAN'T VEER, LAURA J | reporter.nih.gov |
| Biomarkers to Improve Targeting of Breast Cancer Prevention in Women with Atypical Hyperplasia | NIH | National Cancer Institute | 2021 to 2024 | $3,277,143 | January 1, 2020 | December 31, 2024 | DEGNIM, AMY C | reporter.nih.gov |
| SERVICE: Newborn genomic sequencing and federally-supported early intervention | NIH | National Human Genome Research Institute | 2025 | $3,268,197 | September 25, 2025 | June 30, 2029 | MACDUFFIE, KATE E. | reporter.nih.gov |
| Preemptive pharmacogenetic testing in medically underserved populations | NIH | National Human Genome Research Institute | 2021 to 2024 | $3,236,197 | September 1, 2021 | June 30, 2026 | DUARTE, JULIO DAVID | reporter.nih.gov |
| Precision Medicine in the Diagnosis of Genetic Disorders in Neonates | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $3,223,230 | August 15, 2018 | July 31, 2024 | DAVIS, JONATHAN M. | reporter.nih.gov |
| TMEM, MENAcalc, and MENAINV as Prognostic and Predictive Markers for Breast Cancer Metastasis | NIH | National Cancer Institute | 2021 to 2024 | $3,213,083 | July 1, 2020 | June 30, 2025 | ROHAN, THOMAS E | reporter.nih.gov |
| A Stakeholder Informed Randomized Trial of Pretest Video Education vs Standard Genetic Counseling for Cancer Patients: Evaluating the Impact on Patients, Providers and Practices | NIH | National Human Genome Research Institute | 2021 to 2024 | $3,208,986 | September 22, 2021 | June 30, 2026 | RANA, HUMA Q | reporter.nih.gov |
| Islet Dysregulation in Infants with Congenital Hyperinsulinism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,192,917 | August 15, 1999 | June 30, 2025 | DE LEON, DIVA D. | reporter.nih.gov |
| IMProving Care After Inherited Cancer Testing (IMPACT) Study | NIH | National Cancer Institute | 2021 to 2024 | $3,191,801 | September 16, 2020 | August 31, 2025 | PAL, TUYA | reporter.nih.gov |
| Gene Dosage Imbalance in Neurodevelopmental Disorders | NIH | National Institute of Mental Health | 2022 to 2025 | $3,189,018 | March 15, 2005 | December 31, 2026 | MARTIN, CHRISTA LESE | reporter.nih.gov |
| Patient centered prediction of clinically important outcomes arising from pathogenic variants | NIH | National Human Genome Research Institute | 2025 | $3,173,346 | August 15, 2025 | July 31, 2027 | BASTARACHE, LISA | reporter.nih.gov |
| Increasing Access to Genetic Testing in Underserved Patients Using a Multilingual Conversational Agent | NIH | National Cancer Institute | 2022 to 2025 | $3,125,046 | June 1, 2022 | May 31, 2027 | RICKER, CHARITE NICOLETTE | reporter.nih.gov |
| FFNP-PET as a predictive biomarker of response to endocrine therapy approaches in advanced breast cancer | NIH | National Cancer Institute | 2022 to 2025 | $3,111,179 | September 1, 2022 | August 31, 2027 | SHOGHI, KOORESH ISAAC | reporter.nih.gov |
| A Randomized Hybrid Type I effectiveness-implementation study of an Ehealth delivery Alternative for Cancer genetic testing for Hereditary cancer predisposition (eREACH) | NIH | National Cancer Institute | 2021 to 2024 | $3,102,890 | September 17, 2020 | August 31, 2025 | BRADBURY, ANGELA R. | reporter.nih.gov |
| University of Utah Center of Excellence in ELSI research (UCEER) | NIH | National Human Genome Research Institute | 2021 to 2024 | $3,083,339 | May 16, 2016 | May 31, 2025 | ROTHWELL, ERIN | reporter.nih.gov |
| Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,080,631 | February 3, 2021 | January 31, 2027 | LOKSHIN, ANNA E. | reporter.nih.gov |
| Disparities in cancer genetic counseling encounters in the naturalistic clinical setting | NIH | National Cancer Institute | 2022 to 2025 | $3,067,595 | August 15, 2022 | July 31, 2027 | QUILLIN, JOHN M. | reporter.nih.gov |
| The REASON Score: An Epigenetic And Clinicopathologic Score to Predict Risk of Poor Survival in Early Stage Oral Squamous Cell Carcinoma Patients | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $3,001,101 | August 11, 2022 | May 31, 2027 | VIET, CHI T. | reporter.nih.gov |
| Identification Methods, Patient Activation, and Cascade Testing for FH: IMPACT-FH | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,991,274 | August 15, 2019 | July 31, 2028 | MORALES REYES, ANA | reporter.nih.gov |
| Discovery and Characterization of Genetic Risk Loci in Sjogren's Syndrome | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,957,132 | September 7, 2020 | August 31, 2025 | LESSARD, CHRISTOPHER J | reporter.nih.gov |
| Emerging Challenges in NBS: Benefits and Harms of Receiving Uncertain Prognoses After NBS | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,950,254 | September 21, 2022 | August 31, 2027 | TARINI, BETH A | reporter.nih.gov |
| Microphthalmia, Anophthalmia, and Coloboma Genetic Epidemiology in Children (MAGIC) Study | NIH | National Eye Institute | 2021 to 2024 | $2,946,040 | May 1, 2021 | April 30, 2026 | LUPO, PHILIP | reporter.nih.gov |
| Observational study to validate circulating HPVDNA and prognostic genomic biomarkers for diagnosis and treatment of HPV-associated OPSCC | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,942,933 | July 1, 2020 | April 30, 2026 | YARBROUGH, WENDELL G | reporter.nih.gov |
| Human Genetic Variation and Disease | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,936,758 | July 22, 2016 | June 30, 2027 | JORDE, LYNN | reporter.nih.gov |
| Integration of Imaging and Circulating Plasma Cell-Free DNA Sequencing Using MSK-ACCESS to Monitor Treatment Response and Predict Progression in Patients With Multiple Cancers on Targeted Therapy | NIH | National Cancer Institute | 2022 to 2025 | $2,885,730 | July 1, 2022 | June 30, 2027 | BERGER, MICHAEL F. | reporter.nih.gov |
| A population-based virtual solution to reduce gaps in genetic risk evaluation and management in families at high risk for hereditary cancer syndromes: The Georgia-California GeneLINK Trial | NIH | National Cancer Institute | 2021 to 2024 | $2,878,762 | September 15, 2020 | February 28, 2026 | KATZ, STEVEN J. | reporter.nih.gov |
| Genetic Predisposition and Pharmacogenomics of HIV-Associated Cognitive Impairment | NIH | National Human Genome Research Institute | 2021 to 2023 | $2,875,401 | September 10, 2019 | June 30, 2025 | PETER, INGA | reporter.nih.gov |
| Comparing Game Facilitated Interactivity to Genetic Counseling for Prenatal Screening Education | NIH | National Human Genome Research Institute | 2021 to 2024 | $2,875,118 | September 20, 2021 | June 30, 2026 | ROTHWELL, ERIN | reporter.nih.gov |
| The IMproving Access to Genetic INformation for Everyone (IMAGINE) Study: A Prospective Trial of a Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Cancer Patients | NIH | National Cancer Institute | 2021 to 2025 | $2,867,395 | September 16, 2020 | August 31, 2027 | HAMILTON, JADA GABRIELLE | reporter.nih.gov |
| Uncovering the etiologies of non-immune hydrops fetalis through comprehensive genomic analyses and phenotyping | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,851,643 | March 1, 2022 | February 28, 2027 | SPARKS, TERESA N | reporter.nih.gov |
| Uncovering inversion formation in the human genome and its impact to disease. | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $2,819,375 | May 1, 2020 | April 30, 2026 | FONSECA, CLAUDIA CARVALHO | reporter.nih.gov |
| The eXtraordinarY Babies Study: Natural History of Health and Neurodevelopment in Infants with Sex Chromosome Trisomy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,817,119 | September 6, 2017 | March 31, 2028 | TARTAGLIA, NICOLE RENEE | reporter.nih.gov |
| Discovery and characterization of clinically actionable germline mutations in DNA damage repair (DDR) pathway genes in lung cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,799,371 | June 1, 2022 | May 31, 2027 | MUKHERJEE, SEMANTI | reporter.nih.gov |
| Development of Assays for Newborn Screening and for Post-Screening Evaluation of Disease Severity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,785,740 | August 1, 1999 | August 31, 2026 | GELB, MICHAEL H | reporter.nih.gov |
| Comparing Direct and Indirect Methods for Cascade Screening in Familial Hypercholesterolemia (FH) and Long QT Syndrome (LQTS) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,785,718 | June 1, 2022 | May 31, 2027 | BEITELSHEES, AMBER L | reporter.nih.gov |
| A Randomized Controlled Trial: Genetic Counseling Patient Preference Intervention via Electronic Health Record Portal vs. Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,781,114 | January 1, 2021 | December 31, 2026 | SWEET, KEVIN M. | reporter.nih.gov |
| Testing a narrative intervention to enhance genetic counseling and testing | NIH | National Cancer Institute | 2021 to 2025 | $2,779,646 | January 1, 2021 | December 31, 2025 | HURTADO DE MENDOZA CASAUS, ALEJANDRA | reporter.nih.gov |
| Biomarker Approaches to Individualizing Systemic Therapy for High Risk Prostate Cancer | NIH | National Cancer Institute | 2021 to 2024 | $2,771,966 | July 1, 2020 | June 30, 2025 | FENG, FELIX YI-CHUNG | reporter.nih.gov |
| Precision Medicine Policy and Treatment (PreEMPT) Model II | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,764,916 | September 11, 2017 | February 29, 2028 | CHRISTENSEN, KURT DEREK | reporter.nih.gov |
| Multi-cancer early detection using cell-free DNA methylome analysis | NIH | National Cancer Institute | 2023 to 2025 | $2,757,500 | September 19, 2023 | August 31, 2028 | ZHOU, XIANGHONG JASMINE | reporter.nih.gov |
| Applying Population Management Best Practices to Preventive Genomic Medicine | NIH | National Human Genome Research Institute | 2023 to 2025 | $2,742,273 | May 10, 2023 | February 29, 2028 | KNERR, SARAH | reporter.nih.gov |
| Enhancement of Newborn Screening Diagnostic Paradigms to Improve the Efficacy of Treatment for Krabbe Disease, Pompe Disease, and Mucopolysaccharidosis Type 1 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,716,923 | March 18, 2022 | February 28, 2027 | LANGAN, THOMAS J | reporter.nih.gov |
| IGNITE Cost Extension- Year 7 | NIH | National Human Genome Research Institute | 2021 to 2024 | $2,713,750 | July 1, 2024 | June 30, 2025 | ORLANDO, LORI ANN | reporter.nih.gov |
| Computational Pipeline for Identification of Disease-Causing Variants in Genes of the Cardiac Sarcomere | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,685,533 | July 10, 2017 | June 30, 2027 | CAMPBELL, STUART G | reporter.nih.gov |
| NSR-GENE (Neonatal Seizure Registry, GEnetics of post-Neonatal Epilepsy) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,671,951 | March 1, 2022 | February 28, 2027 | GLASS, HANNAH CRANLEY | reporter.nih.gov |
| Advancing equity in colorectal cancer genetic risk prediction through expansion of racial/ethnic minority representation | NIH | National Cancer Institute | 2021 to 2024 | $2,661,057 | July 1, 2020 | June 30, 2025 | PETERS, ULRIKE | reporter.nih.gov |
| Hereditary Genetics of Hepatocellular Carcinoma | NIH | National Cancer Institute | 2022 to 2025 | $2,655,540 | February 1, 2022 | June 30, 2027 | WANGENSTEEN, KIRK J | reporter.nih.gov |
| Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age | NIH | National Cancer Institute | 2021 to 2024 | $2,647,966 | July 1, 2021 | June 30, 2026 | HITCHINS, MEGAN P | reporter.nih.gov |
| Fair Phenotype Annotation and Genomic Reinterpretation | NIH | National Human Genome Research Institute | 2023 to 2025 | $2,646,556 | July 1, 2023 | April 30, 2028 | WENG, CHUNHUA | reporter.nih.gov |
| Liquid biopsy approaches to inform neuroblastoma prognosis and disease monitoring | NIH | National Cancer Institute | 2022 to 2025 | $2,631,965 | April 11, 2022 | March 31, 2027 | APPLEBAUM, MARK ANDREW | reporter.nih.gov |
| NEWBORN SCREENING PILOT STUDIES FOR MUCOPOLYSACCHARIDOSIS TYPE II | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $2,631,501 | September 28, 2021 | September 27, 2024 | RASPA, MELISSA | reporter.nih.gov |
| Implementing a Novel Consent Process for Biospecimen Research after Newborn Screening in Michigan Hospitals | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,622,169 | September 15, 2022 | June 30, 2027 | ROTHWELL, ERIN | reporter.nih.gov |
| Genetic Counseling Processes Result in Outcomes (GC-PRO) Study | NIH | National Human Genome Research Institute | 2022 to 2025 | $2,600,212 | September 21, 2022 | June 30, 2027 | ZIERHUT, HEATHER | reporter.nih.gov |
| Improving Delivery of Genetic Services to High Risk Childhood Cancer Survivors: A Randomized Study of Remote Genetic Services Versus Usual Care | NIH | National Cancer Institute | 2021 to 2024 | $2,593,712 | July 8, 2020 | June 30, 2025 | HENDERSON, TARA OLIVE | reporter.nih.gov |
| Development and Implementation of ElectronicDecision Aids for Genetic Testing in Inherited Cancer Syndromes | NIH | National Cancer Institute | 2021 to 2024 | $2,589,338 | September 14, 2020 | August 31, 2025 | CHUNG, DANIEL C | reporter.nih.gov |
| Phenotype and Genotype of Autosomal Dominant Alzheimer's Disease in Jalisco, Mexico | NIH | National Institute on Aging | 2021 to 2024 | $2,573,193 | September 15, 2020 | May 31, 2026 | RINGMAN, JOHN M | reporter.nih.gov |
| Genome-wide mutational integration for ultra-sensitive plasma tumor burden monitoring in immunotherapy | NIH | National Cancer Institute | 2022 to 2025 | $2,537,016 | June 1, 2022 | May 31, 2027 | LANDAU, DAN | reporter.nih.gov |
| Clinical genomic predictive model of first line androgen receptor inhibitor therapy outcomes in men with mCRPC | NIH | National Cancer Institute | 2022 to 2025 | $2,528,918 | September 16, 2020 | December 31, 2026 | HALABI, SUSAN | reporter.nih.gov |
| Collaborative Research to Explore Genetic Variation and Phenotypic Spectrum of Elastin and Related Genes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,525,727 | March 20, 2020 | February 28, 2026 | WILLIAMS, MARC S. | reporter.nih.gov |
| New York Regional Inborn Errors of Immunity Resource Initiative League (NY-ROYAL) | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,501,144 | September 1, 2023 | August 31, 2028 | MILNER, JOSHUA D. | reporter.nih.gov |
| Imaging genetics of laryngeal dystonia | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,496,823 | March 19, 2012 | July 31, 2028 | SIMONYAN, KRISTINA | reporter.nih.gov |
| Multiplex gene sequencing and metabolomics analysis from newborn dried blood spots to improve screening and diagnosis of metabolic disorders. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,478,251 | September 1, 2020 | May 31, 2026 | SCHARFE, CURT | reporter.nih.gov |
| Imaging signatures of genetic mutations in glioblastoma using machine learning | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,467,136 | June 1, 2002 | November 30, 2025 | DAVATZIKOS, CHRISTOS | reporter.nih.gov |
| Oxytocin sensitivity and postpartum hemorrhage: testing genetic and epigenetic biomarkers for improving maternal morbidity | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,427,305 | August 1, 2023 | May 31, 2028 | ERICKSON, ELISE N | reporter.nih.gov |
| Upgrading rigor and efficiency of germline cancer gene variant classification for the 2020s | NIH | National Cancer Institute | 2022 to 2025 | $2,422,203 | March 1, 2022 | January 31, 2027 | TAVTIGIAN, SEAN VAHRAM | reporter.nih.gov |
| DEVELOPMENT OF AN AUTOMATED CARTRIDGE-BASED BREAST CANCER DETECTION ASSAY- AN ACADEMIC-INDUSTRIAL PARTNERSHIP | NIH | National Cancer Institute | 2022 to 2025 | $2,405,391 | July 11, 2022 | May 31, 2027 | SUKUMAR, SARASWATI | reporter.nih.gov |
| Liquid biopsy of solitary pulmonary nodule with extracellular vesicles | NIH | National Cancer Institute | 2021 to 2025 | $2,402,652 | September 21, 2021 | August 31, 2026 | WAN, YUAN | reporter.nih.gov |
| Urine based circulating tumor DNA analysis | NIH | National Cancer Institute | 2021 to 2025 | $2,390,011 | July 1, 2021 | June 30, 2026 | LAUTENSCHLAEGER, TIM | reporter.nih.gov |
| Validating remote digital assessments for familial frontotemporal dementia | NIH | National Institute on Aging | 2022 | $2,371,437 | May 1, 2022 | April 30, 2025 | STAFFARONI, ADAM MARK | reporter.nih.gov |
| Analysis of urine tumor nucleic acids for detection and personalized surveillance of bladder cancer | NIH | National Cancer Institute | 2021 to 2024 | $2,358,284 | July 1, 2020 | June 30, 2026 | DIEHN, MAXIMILIAN | reporter.nih.gov |
| Engaging Patients in Prenatal Genetic Testing Decisions as a Pathway to Improve Obstetric Outcomes | NIH | National Human Genome Research Institute | 2023 to 2025 | $2,343,205 | September 14, 2017 | February 28, 2027 | FARRELL, RUTH | reporter.nih.gov |
| GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management | NIH | National Cancer Institute | 2023 to 2025 | $2,336,935 | September 1, 2023 | August 31, 2028 | DEL FIOL, GUILHERME | reporter.nih.gov |
| Precision Medicine for Dilated Cardiomyopathy-Cardiac Magnetic Resonance to Identify Early Family Phenotypes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,321,908 | July 1, 2020 | May 31, 2026 | HERSHBERGER, RAY E. | reporter.nih.gov |
| CTSA RC2 Program at University of Utah: A Translational Platform for Rapid Genomic Medicine | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $2,309,657 | June 5, 2023 | May 31, 2028 | TRISTANI-FIROUZI, MARTIN | reporter.nih.gov |
| Genotype First: Actionable Genetic Risk through Genotype-to-Phenotype Prediction | NIH | National Human Genome Research Institute | 2021 to 2023 | $2,287,236 | August 21, 2020 | May 31, 2024 | TORKAMANI, ALI | reporter.nih.gov |
| Combined Methylation and Mutation to Predict Response to PARP Inhibitors | NIH | National Cancer Institute | 2021 to 2024 | $2,278,082 | April 1, 2020 | March 31, 2025 | SWISHER, ELIZABETH MARY | reporter.nih.gov |
| Understanding genetic risk for aneuploid conception | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,266,797 | December 15, 2017 | April 30, 2028 | SCHINDLER, KAREN A | reporter.nih.gov |
| In vivo Perturb-map: scalable genetic screens with single-cell and spatial resolution in intact tissues | NIH | National Human Genome Research Institute | 2023 to 2025 | $2,265,169 | March 2, 2023 | December 31, 2027 | JIN, XIN | reporter.nih.gov |
| Genetic Testing (APOL1) Decisional Support for Potential Living Kidney Donors | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,255,854 | September 30, 2021 | April 30, 2026 | GARDINER, HEATHER MARIE | reporter.nih.gov |
| Monogenic Diabetes: Next Generation Diagnosis, Treatment and Complications | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,234,518 | January 8, 2016 | December 31, 2024 | PHILIPSON, LOUIS H. | reporter.nih.gov |
| Resources for functional studies in Drosophila | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $2,217,293 | April 1, 2022 | December 31, 2025 | PERRIMON, NORBERT | reporter.nih.gov |
| Feasibility and Assessment of a Cascade Traceback Screening program - FACTS | NIH | National Cancer Institute | 2021 to 2023 | $2,213,234 | June 1, 2020 | May 31, 2025 | BUCHANAN, ADAM H | reporter.nih.gov |
| Rapid and affordable magneto-nanosensors for ctDNA-guided lung cancer management | NIH | National Cancer Institute | 2021 to 2024 | $2,197,559 | August 2, 2021 | July 31, 2025 | WANG, SHAN X. | reporter.nih.gov |
| Distinguishing Clinical and Genetic Risk of Suicidal Ideation from Attempts to Inform Prevention | NIH | National Institute of Mental Health | 2021 to 2024 | $2,174,944 | December 1, 2019 | October 31, 2024 | WALSH, COLIN GEORGE | reporter.nih.gov |
| Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer | NIH | National Cancer Institute | 2023 to 2025 | $2,166,917 | June 6, 2023 | May 31, 2028 | SHAH, SOHRAB P | reporter.nih.gov |
| Biomarkers of cognitive decline in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,148,559 | September 19, 2019 | June 30, 2024 | CHEN-PLOTKIN, ALICE S | reporter.nih.gov |
| Biomarker Approach to Screening for the early detection of HPV-related Oropharyngeal Cancer (BASH OPC) | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2025 | $2,145,712 | September 4, 2023 | June 30, 2028 | GIULIANO, ANNA R. | reporter.nih.gov |
| Detection of Emergent Mechanical Properties of Biologically Complex Cellular States | NIH | National Institute of Biomedical Imaging and Bioengineering | 2023 to 2025 | $2,144,508 | August 1, 2017 | February 28, 2027 | SOHN, LYDIA L | reporter.nih.gov |
| Leveraging an electronic medical record infrastructure to identify primary care patients eligible for genetic testing for hereditary cancer and evaluate novel cancer genetics service delivery models | NIH | National Cancer Institute | 2021 to 2022 | $2,143,242 | September 18, 2018 | February 28, 2025 | KAPHINGST, KIMBERLY A | reporter.nih.gov |
| Creation of a knowledgebase of high quality assertions of the clinical actionability of somatic variants in cancer | NIH | National Cancer Institute | 2023 to 2025 | $2,133,377 | September 19, 2023 | August 31, 2028 | GRIFFITH, MALACHI | reporter.nih.gov |
| Curation of genetic defects causing combined immunodeficiency and infections in children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,115,359 | July 1, 2021 | June 30, 2028 | CHINN, IVAN KINGYUE | reporter.nih.gov |
| (PQ3) Integrative biomarkers of cancer progression and therapeutic response from germline and somatic clinical sequencing | NIH | National Cancer Institute | 2021 to 2023 | $2,107,536 | April 1, 2019 | March 31, 2024 | BERGER, MICHAEL F. | reporter.nih.gov |
| Discovery and Characterization of Rare Variant Effects in Dilated Cardiomyopathy via Large-Scale Biobank Analysis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,094,388 | May 15, 2023 | April 30, 2027 | WELLS, QUINN STANTON | reporter.nih.gov |
| Functional genomic resource and integrative model of dopaminergic circuitry associated with psychiatric disease | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,057,596 | May 1, 2019 | February 28, 2025 | AKBARIAN, SCHAHRAM | reporter.nih.gov |
| Platform to support clinical variant interpretation through probabilistic assessment of functional evidence | NIH | National Human Genome Research Institute | 2024 to 2025 | $2,046,556 | January 23, 2023 | May 31, 2027 | SCHAFER, NICHOLAS P | reporter.nih.gov |
| Isabl GxT: A clinically actionable whole genome and transcriptome precision medicine platform | NIH | National Cancer Institute | 2023 to 2024 | $2,033,377 | April 1, 2023 | March 31, 2026 | MEDINA, JUAN SANTIAGO | reporter.nih.gov |
| Addressing Genomic Disparities in Cancer Survivors | NIH | National Cancer Institute | 2023 to 2025 | $2,031,557 | March 9, 2023 | January 31, 2028 | KINNEY, ANITA Y. | reporter.nih.gov |
| Personalizing Post-Polypectomy Surveillance for Colorectal Cancer Prevention | NIH | National Cancer Institute | 2023 to 2025 | $2,027,204 | September 19, 2023 | August 31, 2028 | LEE, JEFFREY KUANG ZOU | reporter.nih.gov |
| An automated device for quantifying DNA damage | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $2,023,277 | February 15, 2019 | July 31, 2026 | ROSS, CHRISTOPHER | reporter.nih.gov |
| Oral Dysplasias to Carcinomas: Multi-omics Study of Progression | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2025 | $2,017,135 | September 1, 2023 | July 31, 2028 | ROZEK, LAURA | reporter.nih.gov |
| Multimodal AI for Precise Clinical and Genetic Diagnosis of Congenital Heart Disease | NIH | Office of the Director, National Institutes of Health | 2025 | $2,013,196 | September 8, 2025 | September 7, 2026 | MILOSAVLJEVIC, ALEKSANDAR | reporter.nih.gov |
| Road Map to Precision Psychiatry: Comprehensive Investigation of Chromosomal Anomalies (PsychMap) | NIH | National Institute of Mental Health | 2021 to 2025 | $2,010,893 | April 1, 2021 | February 28, 2027 | WERGE, THOMAS MEARS | reporter.nih.gov |
| Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA | NIH | National Cancer Institute | 2024 to 2025 | $1,999,999 | September 17, 2024 | August 31, 2026 | BARRETT, MICHAEL T | reporter.nih.gov |
| Robust Predictor of Colon Cancer Risk | NIH | National Cancer Institute | 2022 to 2023 | $1,999,992 | September 13, 2018 | July 31, 2025 | OSTRER, HARRY | reporter.nih.gov |
| Development of An Innovative TEE Technology for Mutation Detection | NIH | National Cancer Institute | 2023 to 2024 | $1,999,735 | September 18, 2023 | August 31, 2025 | DENG, QIPAN | reporter.nih.gov |
| Spatial genomics analysis of tumor samples | NIH | National Cancer Institute | 2023 to 2024 | $1,996,962 | September 1, 2023 | August 31, 2025 | FRIEDA, KIRSTEN | reporter.nih.gov |
| Integrating circulating tumor DNA assay and protein-based MRI to accurately monitor glioma therapy | NIH | National Cancer Institute | 2023 to 2025 | $1,996,509 | July 1, 2023 | June 30, 2028 | JIANG, SHANSHAN | reporter.nih.gov |
| Commercialization of a rapid, automated Hi-C platform for sensitive genomic profiling of multiple cancer sample types | NIH | National Human Genome Research Institute | 2024 to 2025 | $1,993,708 | September 18, 2024 | August 31, 2026 | MUNDING, ELIZABETH | reporter.nih.gov |
| Testing a Low Cost Population- and Theory-Based Outreach Intervention to Engage Ovarian Cancer Survivors and their Close Relatives to Consider Genetic Services | NIH | National Cancer Institute | 2021 to 2023 | $1,991,480 | May 1, 2020 | April 30, 2025 | GUAN, YUE | reporter.nih.gov |
| A state-of-the-art web platform for collaborative, longitudinal genome diagnostics | NIH | National Human Genome Research Institute | 2023 to 2024 | $1,983,298 | September 15, 2023 | August 31, 2025 | WARD, ALISTAIR | reporter.nih.gov |
| Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,983,279 | September 1, 2023 | August 31, 2028 | FAHRMANN, JOHANNES F | reporter.nih.gov |
| Leveraging tumor registries and pathology specimens to facilitate genetic testing and traceback for ovarian cancer | NIH | National Cancer Institute | 2021 to 2023 | $1,967,027 | March 1, 2020 | February 28, 2025 | HUNTER, JESSICA EZZELL | reporter.nih.gov |
| Leveraging human genetics to overcome complex diagnostic challenges, evaluation of pan-ancestry polygenic scores to reduce misdiagnosis of narcolepsy and circadian rhythm sleep wake disorders. | NIH | National Human Genome Research Institute | 2023 to 2025 | $1,966,350 | March 16, 2023 | January 31, 2028 | GOTTLIEB, DANIEL J | reporter.nih.gov |
| Towards an inclusive genomic risk classification for acute myeloid leukemia (AML) | NIH | National Cancer Institute | 2023 to 2025 | $1,961,587 | September 18, 2023 | July 31, 2028 | EISFELD, ANN-KATHRIN | reporter.nih.gov |
| High-throughput size-selection system for long-read sequencing library preparation | NIH | National Human Genome Research Institute | 2024 to 2025 | $1,959,900 | August 3, 2022 | June 30, 2026 | BOLES, TRUETT C | reporter.nih.gov |
| Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus | NIH | National Cancer Institute | 2023 to 2025 | $1,956,820 | December 28, 2022 | November 30, 2027 | STACHLER, MATTHEW D | reporter.nih.gov |
| Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinoma | NIH | National Cancer Institute | 2023 to 2025 | $1,954,067 | July 10, 2023 | June 30, 2028 | LENBURG, MARC ELLIOTT | reporter.nih.gov |
| Integrative analysis of whole genomes and transcriptomes from multiple cell types in rare disease patients | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,948,659 | May 15, 2023 | February 29, 2028 | TURRO, ERNEST | reporter.nih.gov |
| Long-read DNA and RNA sequencing to identify disease-causing genetic variation and streamline testing | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $1,943,750 | September 13, 2022 | August 31, 2027 | MILLER, DANNY ERWIN | reporter.nih.gov |
| Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,922,720 | April 12, 2023 | March 31, 2028 | KIBEL, ADAM S | reporter.nih.gov |
| Large scale single-cell gene rearrangement detection with a microfluidic device | NIH | National Cancer Institute | 2021 to 2025 | $1,921,615 | July 1, 2020 | June 30, 2027 | ZHONG, JOHN | reporter.nih.gov |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) | NIH | National Human Genome Research Institute | 2021 to 2022 | $1,915,725 | September 20, 2018 | June 30, 2023 | CAUDLE, KELLY E. | reporter.nih.gov |
| Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood | NIH | National Cancer Institute | 2021 to 2022 | $1,914,836 | September 6, 2018 | July 31, 2025 | PATEL, ABHIJIT | reporter.nih.gov |
| Inherited and de novo genetic variants relevant to familial, recurrent and sporadic stillbirth | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,894,371 | September 1, 2023 | May 31, 2028 | WORKALEMAHU, TSEGASELASSIE | reporter.nih.gov |
| Novel Epigenetic Test for the Treatment and Improvement of Longitudinal Health-Outcomes for Men with Severe Infertility | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,886,508 | February 5, 2024 | March 31, 2027 | BROGAARD, KRISTIN R | reporter.nih.gov |
| Genomic sequencing to aid diagnosis in pediatric and prenatal practice: Examining clinical utility, ethical implications, payer coverage, and data integration in a diverse population. | NIH | National Human Genome Research Institute | 2021 | $1,862,723 | August 4, 2017 | November 30, 2022 | KWOK, PUI-YAN | reporter.nih.gov |
| Elucidating the Genetic Etiology of Intellectual Disability in African, Asian, and European Families | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,838,529 | August 14, 2023 | July 31, 2028 | LEAL, SUZANNE M | reporter.nih.gov |
| Comprehensive Analysis of Best Practices for Clinical Testing of Malignant Pleural Effusion Specimens | NIH | National Cancer Institute | 2023 to 2025 | $1,828,685 | September 5, 2023 | August 31, 2028 | DEVINE, WALTER PATRICK | reporter.nih.gov |
| Pre-analytical variables of bioanalytes affecting the accuracy of PTCL diagnostic and prognostic genetic signatures | NIH | National Cancer Institute | 2021 to 2025 | $1,827,310 | September 20, 2021 | August 31, 2027 | IQBAL, JAVEED | reporter.nih.gov |
| Rigorous and reproducible mutational analysis of the urinary exosomal DNA | NIH | National Cancer Institute | 2021 to 2023 | $1,825,912 | July 1, 2019 | June 30, 2025 | KALLURI, RAGHU | reporter.nih.gov |
| Clinical and genetic analysis of retinopathy of prematurity | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,821,931 | September 30, 2010 | May 31, 2025 | CAMPBELL, JOHN PETER | reporter.nih.gov |
| Leveraging behavioral economics to equitably implement cascade screening in individuals with familial hypercholesterolemia in partnership with the FH Foundation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,809,952 | March 1, 2022 | February 28, 2027 | BEIDAS, RINAD SARY | reporter.nih.gov |
| Optimization of a personalized skin cancer risk intervention for at-risk young adults | NIH | National Cancer Institute | 2023 to 2025 | $1,806,355 | April 1, 2023 | March 31, 2028 | WU, YELENA PING | reporter.nih.gov |
| Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma | NIH | National Cancer Institute | 2021 to 2022 | $1,795,169 | September 26, 2011 | April 30, 2023 | CHAK, AMITABH | reporter.nih.gov |
| Evaluating an evidence-based family history screening program adapted to increase reach and uptake of screening for BRCA-associated cancers in rural public health clinics | NIH | National Cancer Institute | 2023 to 2025 | $1,789,893 | July 6, 2023 | June 30, 2028 | GUAN, YUE | reporter.nih.gov |
| Mutational signature analysis: methods and applications to the clinic | NIH | National Cancer Institute | 2022 to 2025 | $1,781,683 | May 5, 2022 | April 30, 2027 | PARK, PETER J | reporter.nih.gov |
| Role of energy balance behaviors in modifying biobehavioral risk factors for childhood obesity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,760,499 | March 1, 2023 | December 31, 2027 | KRAL, TANJA V.E. | reporter.nih.gov |
| Evaluating prostate cancer phenotype and genotype classification from circulating tumor DNA as biomarkers for predicting treatment outcomes | NIH | National Cancer Institute | 2023 to 2025 | $1,755,220 | September 19, 2023 | August 31, 2028 | HA, GAVIN | reporter.nih.gov |
| Genomic biomarkers of splenic lymphoma | NIH | National Cancer Institute | 2022 to 2025 | $1,743,045 | October 1, 2022 | November 30, 2026 | ELENITOBA-JOHNSON, KOJO S. J. | reporter.nih.gov |
| Development of an automated, point of care DNA methylation cartridge blood test for colorectal cancer detection in LMICs- an academic-industrial partnership | NIH | National Cancer Institute | 2023 to 2025 | $1,730,278 | June 6, 2023 | May 31, 2028 | SUKUMAR, SARASWATI | reporter.nih.gov |
| A Noninvasive Integrated Genomic Approach for Early Cancer Detection and Risk Stratification after Transplantation | NIH | National Cancer Institute | 2021 to 2023 | $1,728,199 | March 1, 2019 | February 29, 2024 | KHUSH, KIRAN KAUR | reporter.nih.gov |
| GeNYC: Genomic Implementation Research in the Diverse Settings and Populations of New York City | NIH | National Human Genome Research Institute | 2021 to 2024 | $1,724,448 | September 14, 2024 | June 30, 2025 | HOROWITZ, CAROL R | reporter.nih.gov |
| Validation of an aqueous humor liquid biopsy for molecular prognostication and monitoring of children with retinoblastoma. | NIH | National Cancer Institute | 2023 to 2025 | $1,681,542 | August 1, 2023 | July 31, 2028 | BERRY, JESSE L | reporter.nih.gov |
| Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2023 | $1,681,156 | January 1, 2019 | December 31, 2025 | SHU, XIAO-OU | reporter.nih.gov |
| A next-generation method for cytogenomics using Hi-C proximity ligation sequencing | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,675,858 | May 1, 2021 | April 30, 2023 | EACKER, STEPHEN MATTHEW | reporter.nih.gov |
| Improving the throughput of diagnosis and treatment of inherited diseases of the retina | NIH | National Eye Institute | 2021 to 2024 | $1,674,500 | September 1, 2020 | May 31, 2025 | COMANDER, JASON | reporter.nih.gov |
| DNA Repair Capacity Assays for Lung Disease Risk Assessment | NIH | National Cancer Institute | 2021 to 2022 | $1,638,124 | September 1, 2018 | August 31, 2024 | BELINSKY, STEVEN A | reporter.nih.gov |
| Using Markers to Improve Pancreatic Cancer Screening | NIH | National Cancer Institute | 2021 to 2024 | $1,630,491 | July 1, 2013 | June 30, 2025 | GOGGINS, MICHAEL G. | reporter.nih.gov |
| Development of a Multiplex Proteomics Assay for High-Throughput Newborn Screening of a New Set of Treatable Neonatal Diseases | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,622,765 | April 19, 2023 | January 31, 2027 | HAHN, SIHOUN | reporter.nih.gov |
| Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors | NIH | National Human Genome Research Institute | 2021 to 2022 | $1,615,930 | September 13, 2019 | June 30, 2025 | PHILLIPS, ELIZABETH | reporter.nih.gov |
| Development and application of variant interpretation platforms to advance detection of urea cycle disorders by newborn genome sequencing | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,585,181 | May 1, 2024 | February 28, 2029 | DUDLEY, AIMEE M | reporter.nih.gov |
| Liquid Biopsy for treatment stratification of IDH1.R132H and EGFRvIII mutant gliomas | NIH | National Cancer Institute | 2021 to 2022 | $1,582,753 | August 22, 2018 | July 31, 2024 | CARTER, BOB S | reporter.nih.gov |
| Long-term Impact and Value of Infant Genomic Sequencing (LIVING) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,578,227 | September 1, 2024 | May 31, 2029 | CHRISTENSEN, KURT DEREK | reporter.nih.gov |
| Establishing the clinical utility of cell-free tumor DNA methylation profiling as a reliable liquid biopsy approach in brain tumors | NIH | National Cancer Institute | 2022 to 2025 | $1,572,445 | April 1, 2022 | March 31, 2027 | ZADEH, GELAREH | reporter.nih.gov |
| Development of a multi-analyte diagnostic assay to improve the risk stratification of indeterminate thyroid nodules | NIH | National Cancer Institute | 2022 to 2023 | $1,567,219 | August 15, 2022 | July 31, 2025 | KNUDSEN, GISELLE M | reporter.nih.gov |
| Novel whole-genome analysis methods for Alzheimer's risk prediction | NIH | National Institute on Aging | 2023 to 2024 | $1,565,643 | June 15, 2015 | August 31, 2025 | GREYTAK, ELLEN MCRAE | reporter.nih.gov |
| Point of care detection of fluroquinolone, bedaquiline and linezolid resistant Mycobacterium tuberculosis for rapid treatment decisions. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,555,676 | February 26, 2024 | December 31, 2028 | ALLAND, DAVID | reporter.nih.gov |
| Somatic Mutations in Tissue and Saliva as Prognostic and Screening Biomarkers for Oral Premalignancy | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $1,545,269 | July 1, 2020 | April 30, 2026 | AGRAWAL, NISHANT | reporter.nih.gov |
| 5-base HiFi sequencing to advance the understanding of genetic determinants of pregnancy loss | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,523,675 | July 18, 2024 | April 30, 2026 | GRUNDBERG, ELIN | reporter.nih.gov |
| The role of quantitative CT and radiomic biomarkers for precision medicine in pulmonary fibrosis | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,493,792 | February 5, 2024 | January 31, 2029 | NOTH, IMRE | reporter.nih.gov |
| Prenatal Preparation: Actions and Results | NIH | National Human Genome Research Institute | 2021 to 2022 | $1,479,100 | September 12, 2019 | June 30, 2025 | MICHIE, MARSHA MABRY | reporter.nih.gov |
| Improving Genetic Counseling for BRCA+ Mothers | NIH | National Cancer Institute | 2021 to 2024 | $1,472,706 | January 2, 2020 | December 31, 2025 | TERCYAK, KENNETH | reporter.nih.gov |
| Genetic and genomic determinants of homologous recombination repair deficiency as treatment selection markers for lethal prostate cancer | NIH | National Cancer Institute | 2021 to 2024 | $1,464,602 | December 3, 2019 | November 30, 2025 | LUO, JUN | reporter.nih.gov |
| Machine Learning Guided Precision Genetic Testing for Identification of Monogenic Cardiovascular Disorders | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,462,209 | July 1, 2024 | May 31, 2028 | SHAH, SVATI H. | reporter.nih.gov |
| Translation of a biomarker panel for the early detection of hepatocellular carcinoma | NIH | National Cancer Institute | 2021 to 2023 | $1,458,768 | September 18, 2019 | August 31, 2024 | MEHTA, ANAND S. | reporter.nih.gov |
| Design of a Scalable and Sustainable PREMMplus Patient-Facing App and Implementation in Three Healthcare Settings | NIH | National Cancer Institute | 2024 to 2025 | $1,455,977 | September 4, 2024 | August 31, 2029 | SYNGAL, SAPNA | reporter.nih.gov |
| Leveraging Large-Scale Biobanks to Discover and Define Rare Variant Effects in Hypertrophic Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,452,595 | August 1, 2024 | July 31, 2028 | WELLS, QUINN STANTON | reporter.nih.gov |
| 3D carbon-nanotubes integrated microdevice for extracellular vesicle isolation and in situ sample preparation towards noninvasive pancreatic cancer diagnosis | NIH | National Cancer Institute | 2021 to 2023 | $1,444,026 | August 10, 2019 | July 31, 2025 | ZHENG, SIYANG | reporter.nih.gov |
| A Randomized Trial of Chatbot for Prenatal Genetic Counseling | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,443,134 | September 18, 2024 | August 31, 2029 | TUULI, METHODIUS GAMUO | reporter.nih.gov |
| AYA ACCESS Study: An enhanced eHealth and Chat-bot enabled delivery model for clinical genetic services in community AYA cancer patients | NIH | National Cancer Institute | 2024 to 2025 | $1,442,143 | April 1, 2024 | March 31, 2029 | BRADBURY, ANGELA R. | reporter.nih.gov |
| Optimizing genetic risk models for primary open-angle glaucoma through expanded population genomic analysis | NIH | National Eye Institute | 2024 to 2025 | $1,435,274 | July 1, 2022 | June 30, 2027 | COOKE BAILEY, JESSICA N | reporter.nih.gov |
| Peer Support for Young Adult Women with High Breast Cancer Risk | NIH | National Cancer Institute | 2021 to 2024 | $1,415,169 | January 1, 2020 | December 31, 2025 | O'NEILL, SUZANNE C. | reporter.nih.gov |
| MAGNET: MAKING GENOMICS ACCESSIBLE FOR NEWBORNS IN TEXAS | NIH | National Human Genome Research Institute | 2024 to 2025 | $1,411,200 | September 25, 2024 | July 31, 2029 | LEE, BRENDAN | reporter.nih.gov |
| Development of Non-invasive Liquid Biopsy Screening Tool for Preterm Birth Causes and Consequences | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,410,779 | August 13, 2024 | July 31, 2029 | PETERS, DAVID GERARD | reporter.nih.gov |
| Inflammation-related gene biomarkers in human diabetic foot ulcer healing | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,408,029 | July 4, 2022 | June 30, 2027 | SPILLER, KARA LORRAINE | reporter.nih.gov |
| Clarifying risk and protective factors for dementia with the Interplay of Genes and Environment in Multiple Studies (IGEMS) consortium | NIH | National Institute on Aging | 2021 to 2022 | $1,406,680 | September 1, 2018 | March 31, 2025 | GATZ, MARGARET | reporter.nih.gov |
| Inherited genetic variation and penetrance of Hereditary Paraganglioma-Pheochromocytoma Syndrome | NIH | National Cancer Institute | 2021 to 2024 | $1,399,914 | August 4, 2020 | April 30, 2026 | FISHBEIN, LAUREN MICHELLE | reporter.nih.gov |
| Nanoreactor beads for POC TB resistance testing | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,388,246 | November 7, 2023 | October 31, 2028 | ALLAND, DAVID | reporter.nih.gov |
| Evaluation of the effect of patient-context factors and sample acquisition on the quality and analytical performance of cell-free DNA and circulating tumor cells profiling assays in prostate cancer pa | NIH | National Cancer Institute | 2021 to 2024 | $1,387,631 | September 8, 2020 | August 31, 2025 | ARCILA, MARIA E | reporter.nih.gov |
| The Role of Genetic Risk Factors in Keratinocyte Carcinoma Susceptibility | NIH | National Cancer Institute | 2021 to 2025 | $1,387,132 | March 1, 2020 | December 31, 2026 | CHOQUET, HELENE | reporter.nih.gov |
| A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers | NIH | National Cancer Institute | 2024 to 2025 | $1,381,782 | September 1, 2024 | August 31, 2029 | KANETSKY, PETER A | reporter.nih.gov |
| Predicting Clinical Phenotypes in Crohn's Disease Using Machine Learning and Single-Cell 'omics | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $1,381,450 | May 1, 2023 | April 30, 2027 | SYED, SANA | reporter.nih.gov |
| Finding Missing Genetic Causality of Inherited Retinal Degenerations | NIH | National Eye Institute | 2024 to 2025 | $1,369,782 | September 30, 2024 | April 30, 2028 | BUJAKOWSKA, KINGA | reporter.nih.gov |
| Unresolved Issues in Newborn Screening: Quantifying the Harms of a False Positive Result | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,369,674 | September 15, 2018 | June 30, 2025 | TARINI, BETH A | reporter.nih.gov |
| Personalizing genetic test results management and outcomes after diagnosis of cancer: the Georgia-California SEER Genelink Study | NIH | National Cancer Institute | 2024 to 2025 | $1,362,587 | March 5, 2024 | February 28, 2029 | KURIAN, ALLISON W. | reporter.nih.gov |
| Live embryo imaging for biopsy-free aneuploidy detection | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,362,173 | August 1, 2024 | April 30, 2029 | YU, BO | reporter.nih.gov |
| Developing liquid biopsy tests for malignant effusions using artificial intelligence-assisted, morphology-based isolation of tumor cells | NIH | National Cancer Institute | 2024 to 2025 | $1,355,263 | August 12, 2024 | July 31, 2029 | MAGBANUA, MARK JESUS | reporter.nih.gov |
| Evaluation of treatment predictors reflecting beta-catenin activation in hepatocellular carcinoma | NIH | National Cancer Institute | 2021 to 2025 | $1,345,287 | July 1, 2021 | June 30, 2028 | KWEE, SANDI ALEXANDER | reporter.nih.gov |
| An innovative integrated computational framework using gene signatures for patient stratification | NIH | National Cancer Institute | 2023 to 2025 | $1,343,498 | December 8, 2022 | November 30, 2027 | CHENG, CHAO | reporter.nih.gov |
| Genetic Diagnosis of Neurodevelopmental Disorders in India | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,342,303 | September 10, 2018 | February 28, 2025 | BIELAS, STEPHANIE LEE | reporter.nih.gov |
| Cellular Phenotypes of Genetic Variants in Mucopolysaccharidosis | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,338,069 | April 1, 2023 | March 31, 2028 | DICKSON, PATRICIA I | reporter.nih.gov |
| Identification of glycosaminoglycans for newborn screening and therapeutic monitoring of mucopolysaccharidoses | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,331,791 | September 21, 2021 | August 31, 2024 | NG, RAINER | reporter.nih.gov |
| Leveraging biobank-scale whole-genome sequencing for polygenic risk prediction | NIH | National Human Genome Research Institute | 2023 to 2025 | $1,324,600 | September 18, 2023 | July 31, 2027 | LOH, PO-RU | reporter.nih.gov |
| Deep Mutational Scanning of Monogenic Diabetes Genes to Facilitate Precision Diagnostics for Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,301,734 | September 1, 2024 | May 31, 2029 | GLOYN, ANNA LOUISE | reporter.nih.gov |
| Development of blood-based methylation biomarkers for CRC risk prediction | NIH | National Cancer Institute | 2023 to 2025 | $1,300,887 | September 20, 2023 | August 31, 2028 | GHOSH, JAYASHRI | reporter.nih.gov |
| Single-molecule nanopore-based identification of methylome signatures in cfDNA for early colorectal cancer detection | NIH | National Cancer Institute | 2024 to 2025 | $1,280,475 | September 1, 2024 | August 31, 2029 | JI, HANLEE P | reporter.nih.gov |
| Empowering Interoperable Genomics-Enabled Learning Health Systems at Scale | NIH | National Human Genome Research Institute | 2024 to 2025 | $1,273,249 | September 23, 2024 | July 31, 2029 | KAWAMOTO, KENSAKU | reporter.nih.gov |
| Pre-Symptomatic Familial ALS (Pre-fALS) Study - Prelude to a Treatment Trial | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,272,742 | September 15, 2018 | August 31, 2024 | BENATAR, MICHAEL | reporter.nih.gov |
| Improving Genetic Diagnosis for African Ancestry Populations | NIH | National Human Genome Research Institute | 2023 to 2024 | $1,267,851 | September 20, 2023 | June 30, 2027 | O'DONNELL-LURIA, ANNE | reporter.nih.gov |
| Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options | NIH | National Human Genome Research Institute | 2025 | $1,264,651 | September 18, 2023 | August 31, 2027 | SCHERER, ANDREAS | reporter.nih.gov |
| Randomized clinical trial of the sequence of genetic counseling and testing to optimize efficiency, patient empowerment and engagement, and medical adherence for diverse genetic testing indications | NIH | National Human Genome Research Institute | 2021 to 2024 | $1,253,700 | September 22, 2021 | June 30, 2026 | JAMES, CYNTHIA A | reporter.nih.gov |
| A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies | NIH | National Cancer Institute | 2022 to 2024 | $1,249,508 | September 5, 2022 | August 31, 2025 | WANG, TZA-HUEI JEFF | reporter.nih.gov |
| Pathogenic Germline Mutations in Barrett's Esophagus | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,242,775 | August 15, 2024 | May 31, 2029 | GALA, MANISH | reporter.nih.gov |
| Massively Parallel Biochemical Annotation of Missense DNA Variants to Support Newborn Screening by Whole Genome Sequencing | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,222,737 | August 23, 2024 | June 30, 2028 | GELB, MICHAEL H | reporter.nih.gov |
| The contribution of RAD51C and RAD51D to breast and ovarian cancer | NIH | National Cancer Institute | 2021 to 2024 | $1,217,733 | May 1, 2018 | November 30, 2024 | COUCH, FERGUS JOSEPH | reporter.nih.gov |
| Predictive Biomarkers for disease activity and organ damage in patients with lupus | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,211,313 | May 27, 2018 | April 30, 2024 | TSAO, BETTY P | reporter.nih.gov |
| Precision DNA methylation test to reduce oral cancer disparities in African Americans patients residing in low-resource settings | NIH | National Cancer Institute | 2023 to 2025 | $1,205,344 | September 20, 2023 | May 31, 2027 | GUERRERO-PRESTON, RAFAEL | reporter.nih.gov |
| Clinical and Molecular Biomarkers of Endpoints in Pediatric Renal Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,176,120 | September 15, 2020 | August 31, 2025 | SEIFERT, MICHAEL EDWARD | reporter.nih.gov |
| Multiplex Proteomic Analysis for Next-Generation Newborn Screening of Wilson Disease, Cystinosis, and Primary Immunodeficiencies | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,172,840 | May 15, 2019 | April 30, 2024 | HAHN, SIHOUN | reporter.nih.gov |
| ClinGen Expert Curation Panel for the Epilepsies | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,168,722 | August 1, 2021 | July 31, 2025 | MEFFORD, HEATHER C. | reporter.nih.gov |
| Robust Predictor of Breast Cancer Risk | NIH | National Cancer Institute | 2021 to 2022 | $1,168,203 | September 20, 2017 | June 30, 2023 | OSTRER, HARRY | reporter.nih.gov |
| Expert curation of sequence variants in the proximal urea cycle genes | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,167,215 | June 1, 2023 | May 31, 2027 | CALDOVIC, LJUBICA MORIZONO | reporter.nih.gov |
| Cell free nucleic acid-based biomarkers in advanced prostate cancer | NIH | National Cancer Institute | 2021 to 2022 | $1,162,841 | August 1, 2017 | January 31, 2025 | WANG, LIANG | reporter.nih.gov |
| Multimodal machine learning for diagnosis and mechanistic phenotyping of inherited diseases | NIH | Office of the Director, National Institutes of Health | 2025 | $1,156,956 | June 6, 2025 | June 5, 2027 | WANG, KAI | reporter.nih.gov |
| GLIA-CTN Genomic Expert Curation Panel | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,147,659 | July 15, 2023 | May 31, 2026 | VANDERVER, ADELINE LUCIE | reporter.nih.gov |
| Identification and Functional Evaluation of Autosomal Recessive Nonsyndromic Hearing Impairment Genes in sub-Saharan Africans | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2022 | $1,145,427 | September 1, 2018 | August 31, 2025 | LEAL, SUZANNE M | reporter.nih.gov |
| Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs | NIH | National Cancer Institute | 2024 to 2025 | $1,144,229 | March 11, 2024 | February 28, 2029 | TORRES, KEILA ENITT | reporter.nih.gov |
| A Rapid and Comprehensive Approach for Clinical Genomic Profiling in Lung Cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,143,058 | May 1, 2023 | April 30, 2027 | DUNCAVAGE, ERIC J | reporter.nih.gov |
| Molecular markers of risk of subsequent invasive breast cancer in women wth ductal carcinoma in situ | NIH | National Cancer Institute | 2021 | $1,134,871 | September 15, 2017 | July 31, 2024 | ROHAN, THOMAS E | reporter.nih.gov |
| Statistical Methods for Prospective Evaluation of Biomarkers | NIH | National Cancer Institute | 2021 to 2024 | $1,103,772 | September 4, 2009 | June 30, 2025 | ZHENG, YINGYE | reporter.nih.gov |
| Background free amplified single-molecule FISH for in situ and flow cytometric applications | NIH | National Cancer Institute | 2021 to 2022 | $1,103,511 | February 16, 2018 | January 31, 2025 | TYAGI, SANJAY | reporter.nih.gov |
| Genetic and Epigenetic Biomarkers for B-cell Lymphoma | NIH | National Cancer Institute | 2021 to 2023 | $1,090,132 | January 1, 2020 | June 30, 2025 | YOUNG, KEN H. | reporter.nih.gov |
| Systematic liquid biopsy to monitor residual disease and treatment efficacy in gastrointestinal cancer patients | NIH | National Cancer Institute | 2022 to 2025 | $1,079,955 | September 5, 2022 | June 30, 2027 | PARIKH, APARNA RAJ | reporter.nih.gov |
| ClinGen Expert Curation Panel for Severe Structural Anomalies and Stillbirth | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,057,364 | September 1, 2021 | August 31, 2025 | WAPNER, RONALD | reporter.nih.gov |
| Expert curation of clinically significant variants in genes for early onset retinal degeneration | NIH | National Eye Institute | 2022 to 2024 | $1,052,237 | July 1, 2022 | May 31, 2025 | DUNCAN, JACQUE LYNNE | reporter.nih.gov |
| Modernized Culturally Sensitive Family Medical History Tool | NIH | National Institute on Minority Health and Health Disparities | 2025 | $1,051,406 | September 18, 2025 | May 31, 2027 | LUNDSTROM, JULIE | reporter.nih.gov |
| Genetic studies of homologous recombination deficiency in hispanic gastric cancer | NIH | National Cancer Institute | 2021 to 2022 | $1,050,582 | June 8, 2018 | May 31, 2024 | CARVAJAL CARMONA, LUIS GUILLERMO | reporter.nih.gov |
| A prognostic mRNA immune signature for resected stage II-III melanoma | NIH | National Cancer Institute | 2022 to 2024 | $1,050,317 | June 13, 2019 | March 31, 2025 | SAENGER, YVONNE MARGARET | reporter.nih.gov |
| Genomic Clinical Variant Expert Curation Panel for Monogenic Diabetes: A Gateway to Precision Medicine in Diabetes Mellitus | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,042,875 | June 1, 2023 | May 31, 2026 | POLLIN, TONI I. | reporter.nih.gov |
| Massively-parallel functional interrogation of genetic variation in CMD-associated alpha-dystroglycan glycosylating enzymes | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,039,693 | September 26, 2023 | June 30, 2028 | HALLER, GABRIEL E | reporter.nih.gov |
| Rapid, simple, and ultrasensitive quantitation of KRAS ctDNA at the point of care using CRISPR/Cas amplification and digital resolution biosensor microscopy | NIH | National Cancer Institute | 2023 to 2025 | $1,035,969 | August 1, 2023 | July 31, 2027 | CUNNINGHAM, BRIAN T. | reporter.nih.gov |
| Multifactor risk scores with susceptibility gene mutations to enhance risk assessment of pancreatic cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,032,669 | September 19, 2023 | August 31, 2028 | OBERG, ANN LAURA | reporter.nih.gov |
| Methods for improving clinical diagnostic by detection, prediction, interpretation and prioritization of aberrant transcriptome variations | NIH | National Library of Medicine | 2021 to 2023 | $1,026,394 | August 3, 2020 | July 31, 2025 | BARASH, YOSEPH | reporter.nih.gov |
| Genetic Counseling Fellowship in Research Training (GC-FIRST) | NIH | National Human Genome Research Institute | 2022 to 2025 | $1,022,756 | June 15, 2022 | March 31, 2027 | ZIERHUT, HEATHER | reporter.nih.gov |
| Cost Effectiveness of Germline Genetic Testing in Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2024 | $1,009,656 | March 1, 2020 | August 31, 2025 | PETERS, MARY LINTON B | reporter.nih.gov |
| InheRET: A SaaS solution to identify patients at increased risk for hereditary disease. | NIH | National Cancer Institute | 2021 | $995,667 | May 1, 2019 | February 28, 2023 | KEREN, DAVID FREEMAN | reporter.nih.gov |
| Urine Diagnostic Tool for the Detection of High-grade Prostate Cancer | NIH | National Cancer Institute | 2021 | $995,327 | September 1, 2020 | August 31, 2022 | NIKNAFS, YASHAR SHARIFI | reporter.nih.gov |
| Curation Expert Panels for BRCA1/2 and Hereditary Breast, Ovarian and Pancreatic (HBOP) Cancer Genes | NIH | National Cancer Institute | 2022 to 2025 | $987,571 | August 10, 2022 | July 31, 2028 | COUCH, FERGUS JOSEPH | reporter.nih.gov |
| Molecular and clinical evaluation of the glioma patient experience to anticipate modern outcomes and guide patient care | NIH | National Cancer Institute | 2021 to 2023 | $967,267 | August 8, 2018 | July 31, 2024 | POISSON, LAILA M | reporter.nih.gov |
| Using electronic medical record data to shorten diagnostic odysseys for rare genetic disorders in children and adults in two New York City health care settings | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $963,482 | February 1, 2024 | January 31, 2027 | GELB, BRUCE D | reporter.nih.gov |
| Liquid Biopsy for Rapid Detection and Real Time Monitoring of FGFR-altered Cancers | NIH | National Cancer Institute | 2023 to 2025 | $957,430 | September 22, 2021 | August 31, 2026 | ROYCHOWDHURY, SAMEEK | reporter.nih.gov |
| DSPP Function, Pathophysiology, and Genetic Diagnosis | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $955,046 | September 1, 2018 | May 31, 2024 | SIMMER, JAMES P | reporter.nih.gov |
| Clinical Sequencing Core Facility for the Undiagnosed Diseases Network (UDN) | NIH | National Human Genome Research Institute | 2021 | $951,000 | September 22, 2014 | June 30, 2024 | ENG, CHRISTINE | reporter.nih.gov |
| Expanding Access to Genetic Evaluation Through Virtual Platforms | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $930,000 | February 1, 2022 | January 31, 2027 | LALANI, SEEMA R | reporter.nih.gov |
| Access to Genetic Information Leveraging Innovative Technology (AGILITY) Study | NIH | National Human Genome Research Institute | 2021 to 2022 | $926,755 | September 22, 2021 | February 29, 2024 | HUNTER, JESSICA EZZELL | reporter.nih.gov |
| Combined NGS tumor-based detection of germline Lynch syndrome mutations and prognostic classification of endometrial cancers | NIH | National Cancer Institute | 2021 to 2022 | $925,110 | July 6, 2018 | June 30, 2024 | GOODFELLOW, PAUL JOSEPH | reporter.nih.gov |
| Liquid Biopsy in Glioblastoma Treated with Chemoradiation and an Oxygen Therapeutic | NIH | National Cancer Institute | 2025 | $919,366 | September 22, 2025 | August 31, 2027 | UNGER, EVAN CHARLES | reporter.nih.gov |
| Comprehensive minimal residual disease tracking in cancer | NIH | National Cancer Institute | 2024 to 2025 | $908,380 | June 1, 2018 | November 30, 2026 | MAKRIGIORGOS, G. MIKE | reporter.nih.gov |
| Clinical and Translational studies in muscle disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $903,972 | July 1, 2018 | June 30, 2028 | WEIHL, CONRAD C | reporter.nih.gov |
| Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment | NIH | National Cancer Institute | 2021 to 2022 | $901,778 | September 30, 2008 | January 31, 2025 | SYNGAL, SAPNA | reporter.nih.gov |
| Methylation and Mutation Assay to Personalize PARP Inhibitor Therapy | NIH | National Cancer Institute | 2021 to 2022 | $900,690 | September 1, 2020 | May 31, 2024 | SWISHER, ELIZABETH MARY | reporter.nih.gov |
| Biomarker Validation in Pancreatic Cystic Neoplasms | NIH | National Cancer Institute | 2023 | $898,256 | September 15, 2023 | March 15, 2024 | SIMEONE, DIANE M | reporter.nih.gov |
| The mechanistic basis for constitutional MLH1 methylation (epimutation) | NIH | National Cancer Institute | 2021 to 2022 | $891,477 | September 18, 2019 | July 31, 2024 | HITCHINS, MEGAN P | reporter.nih.gov |
| Utilizing long-read sequencing to resolve inconclusive diagnoses and uncertainty in genetic testing | NIH | National Human Genome Research Institute | 2024 to 2025 | $890,000 | April 1, 2024 | January 31, 2028 | RAJAGOPALAN, RAMAKRISHNAN | reporter.nih.gov |
| Myeloid Malignancy Variant Curation Expert Panel | NIH | National Cancer Institute | 2023 to 2025 | $883,002 | April 20, 2021 | June 30, 2027 | GODLEY, LUCY ANN | reporter.nih.gov |
| Elucidating the barriers and facilitators to widespread implementation of preconception genetic carrier screening | NIH | National Human Genome Research Institute | 2022 to 2025 | $882,832 | February 1, 2022 | January 31, 2027 | HULL, LELAND | reporter.nih.gov |
| Advanced machine learning to empower ultra-sensitive liquid biopsy in melanoma and non-small cell lung cancer | NIH | National Cancer Institute | 2023 to 2025 | $877,791 | July 4, 2023 | June 30, 2028 | WIDMAN, ADAM | reporter.nih.gov |
| A comparison of environmental and genetic risks for schizophrenia and bipolar disorder: A Swedish national study | NIH | National Institute of Mental Health | 2021 to 2023 | $874,461 | May 18, 2020 | February 28, 2026 | BERGEN, SARAH E | reporter.nih.gov |
| Biomarker Validation in Pancreatic Cystic Neoplasms | NIH | National Cancer Institute | 2024 to 2025 | $869,561 | September 15, 2023 | August 31, 2029 | SIMEONE, DIANE M | reporter.nih.gov |
| Predictive markers for personalized therapy in chronic lymphocytic leukemia | NIH | National Cancer Institute | 2023 to 2025 | $857,793 | April 1, 2023 | March 31, 2028 | SOUMERAI, JACOB | reporter.nih.gov |
| Microphthalmia, Anophthalmia, and Coloboma Genetic Epidemiology in Children (MAGIC) Study | NIH | National Eye Institute | 2025 | $851,567 | May 1, 2021 | April 30, 2027 | LUPO, PHILIP | reporter.nih.gov |
| Early detection of bladder cancer through urothelial cell enrichment and DNA flow cytometry | NIH | National Cancer Institute | 2023 to 2025 | $838,824 | July 1, 2023 | June 30, 2028 | DUDLEY, JONATHAN CARL | reporter.nih.gov |
| Characterizing microvascular impairment in adults with elevated genetic risk for Alzheimer's Disease | NIH | National Institute on Aging | 2025 | $831,583 | March 15, 2025 | January 31, 2030 | JUTTUKONDA, MEHER R | reporter.nih.gov |
| Supporting pregnant patients as they face a changing landscape of prenatal genetic tests and post-diagnosis options | NIH | National Human Genome Research Institute | 2024 | $831,046 | September 18, 2024 | August 31, 2025 | FARRELL, RUTH | reporter.nih.gov |
| Facilitated Education and Testing in BRCA Positive Families | NIH | National Cancer Institute | 2021 to 2022 | $827,714 | June 8, 2018 | May 31, 2025 | SCHWARTZ, MARC D | reporter.nih.gov |
| Use of Tiered Genetic Sequencing and Specialty Referral for Identifying and Managing Rare Genetic Causes of Chronic Suppurative Respiratory Disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $826,852 | January 15, 2024 | December 31, 2027 | OLIVIER, KENNETH N. | reporter.nih.gov |
| Understanding and predicting relapse in acute myeloid leukemia | NIH | National Cancer Institute | 2022 to 2023 | $819,280 | July 1, 2013 | May 31, 2024 | RADICH, JERALD PATRICK | reporter.nih.gov |
| Integrative Somatic and Germline Computational Biology to Redefine Clinical Actionability in Solid Tumors | NIH | National Cancer Institute | 2021 to 2022 | $814,350 | June 1, 2018 | May 31, 2023 | VAN ALLEN, ELIEZER M | reporter.nih.gov |
| Supporting Just-in-Time Consent for Prenatal Screening in Diverse Populations | NIH | National Human Genome Research Institute | 2024 | $812,285 | September 18, 2024 | June 30, 2028 | ALLYSE, MEGAN A. | reporter.nih.gov |
| FIGOR: Fellowship In Genomics Outcomes Research | NIH | National Human Genome Research Institute | 2023 to 2025 | $807,248 | September 1, 2023 | June 30, 2028 | COX, NANCY J | reporter.nih.gov |
| Precision Medicine Approaches to Obesity Pharmacotherapy in Youth with Severe Obesity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $804,868 | August 1, 2020 | May 31, 2025 | BOMBERG, ERIC MORRIS | reporter.nih.gov |
| Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future | NIH | National Cancer Institute | 2021 to 2022 | $800,130 | September 19, 2018 | August 31, 2025 | YEH, JENNIFER M. | reporter.nih.gov |
| Validating remote digital assessments for familial frontotemporal dementia | NIH | National Institute on Aging | 2025 | $798,073 | May 1, 2022 | April 30, 2027 | STAFFARONI, ADAM MARK | reporter.nih.gov |
| Feasibility and validation of an integrated newborn screening algorithm with targeted Next Generation Sequencing (tNGS) technology as part of a 2nd-tier test for Pompe and MPS I | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $793,462 | August 16, 2018 | December 31, 2022 | AMIN, VIREN R | reporter.nih.gov |
| The Role of Alzheimer's Disease Genetic Risk in Predicting Parkinson's Disease Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $793,430 | September 15, 2020 | June 30, 2025 | TROPEA, THOMAS FRANCIS | reporter.nih.gov |
| Colorectal Cancer Molecular Subtype Assay Development and Validation | NIH | National Cancer Institute | 2021 to 2023 | $787,854 | September 21, 2018 | August 31, 2025 | MARU, DIPEN M. | reporter.nih.gov |
| Genetic profiling of childhood glaucoma in India | NIH | National Eye Institute | 2024 to 2025 | $786,250 | September 30, 2024 | July 31, 2027 | WIGGS, JANEY L | reporter.nih.gov |
| Precision Medicine for Dilated Cardiomyopathy—Novel Assessment of Cardiac Mechanics via Speckle Tracking Echocardiography to Identify Early Phenotypes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $785,953 | August 1, 2019 | June 30, 2025 | HERSHBERGER, RAY E. | reporter.nih.gov |
| Advanced method for preparing cell-free DNA sequencing libraries | NIH | National Human Genome Research Institute | 2021 | $785,533 | May 1, 2017 | July 31, 2023 | KAZAKOV, SERGEI A | reporter.nih.gov |
| Advancing Genomic Interpretation for Chromatin Remodeling Enzymes | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $780,000 | September 15, 2024 | August 31, 2029 | ZIMMERMANN, MICHAEL T | reporter.nih.gov |
| Characterizing the progression of Alzheimer's disease with multi-omic genetic and imaging data | NIH | National Institute on Aging | 2024 to 2025 | $776,277 | September 30, 2024 | July 31, 2029 | YAN, JINGWEN | reporter.nih.gov |
| Supporting Just-in-Time Consent for Prenatal Screening | NIH | National Human Genome Research Institute | 2025 | $774,052 | April 1, 2025 | June 30, 2028 | MICHIE, MARSHA MABRY | reporter.nih.gov |
| Decision Support for Multigene Panel Testing and Family Risk Communication among Racially/Ethnically Diverse Young Breast Cancer Survivors | NIH | National Cancer Institute | 2021 to 2025 | $772,525 | July 1, 2021 | June 30, 2027 | JONES, TARSHA | reporter.nih.gov |
| A reference-free computational algorithm for comprehensive somatic mosaic mutation detection | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $769,282 | April 1, 2023 | March 31, 2025 | MARTH, GABOR T | reporter.nih.gov |
| Phase II: Rapid Array Diagnosis of Congenital Heart Defects (RAD4CHD) Using Allele Diagnostics Rapid Array Chromosomal Microarray Strategy | NIH | National Heart, Lung, and Blood Institute | 2021 | $768,564 | March 1, 2019 | May 31, 2022 | TORCHIA, BETH | reporter.nih.gov |
| Lung Cancer FAST (Fragment Analysis, SNP, and Translocations) Testing | NIH | National Cancer Institute | 2025 | $764,448 | August 1, 2025 | July 31, 2028 | BROWN, JUSTIN T | reporter.nih.gov |
| Facilitating the Implementation of Population-wide Genomic Screening (FOCUS) | NIH | National Human Genome Research Institute | 2025 | $757,994 | September 5, 2024 | June 30, 2029 | ALLEN, CAITLIN GLOECKNER | reporter.nih.gov |
| Brain Malformation Expert Panels for Gene and Variant Curation | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $755,436 | May 1, 2024 | April 30, 2027 | PODURI, ANNAPURNA | reporter.nih.gov |
| Advancing Perinatal Genomic Discoveries through Patient Engagement and Data Sharing | NIH | National Human Genome Research Institute | 2025 | $754,561 | August 14, 2025 | June 30, 2029 | RIGGS, ERIN ROONEY | reporter.nih.gov |
| InSiGHT-ClinGen Polyposis/Colon Cancer Variant Curation Expert Panel | NIH | National Cancer Institute | 2021 to 2024 | $745,538 | June 10, 2021 | May 31, 2026 | GREENBLATT, MARC S | reporter.nih.gov |
| Clinicopathologic and Genetic Profiling through Machine Learning and Natural Language Processing for Precision Lung Cancer Management | NIH | National Cancer Institute | 2021 to 2022 | $742,797 | September 25, 2019 | August 31, 2024 | HASSANPOUR, SAEED | reporter.nih.gov |
| Understanding the Role of Somatic Mutations in Adult Inflammatory Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $739,530 | January 1, 2022 | December 31, 2025 | BECK, DAVID | reporter.nih.gov |
| Decision-Making in Genetic FTD | NIH | National Institute on Aging | 2021 | $731,351 | September 1, 2004 | February 29, 2024 | CHIONG, WINSTON | reporter.nih.gov |
| Plasma Cell-Free RNA as Non-invasive Biomarker for Neurodegeneration | NIH | National Institute on Aging | 2022 to 2024 | $729,126 | February 1, 2020 | March 31, 2026 | IBANEZ, LAURA | reporter.nih.gov |
| New quantitative approaches to interpret variant pathogenicity | NIH | National Human Genome Research Institute | 2023 to 2025 | $727,022 | September 17, 2021 | December 31, 2025 | FAN, XIAO | reporter.nih.gov |
| Ultrasensitive detection of circulating DNA methylation for head and neck cancer prognosis | NIH | National Institute of Dental & Craniofacial Research | 2025 | $716,123 | September 8, 2025 | May 31, 2030 | CHUNG, CHRISTINE H | reporter.nih.gov |
| Integration of multimodal cancer predisposition genetic counseling practices within the pediatric oncology setting | NIH | National Human Genome Research Institute | 2021 to 2022 | $715,412 | September 1, 2021 | August 31, 2025 | MACFARLAND, SUZANNE PATRICIA | reporter.nih.gov |
| Population Assessments of Aggregate Genetic Risk for Dilated Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $712,775 | August 15, 2021 | September 30, 2025 | ARAGAM, KRISHNA G | reporter.nih.gov |
| Lipid nanoprobe integrated microdevice for extracellular vesicle isolation and duplex sequencing based mutation detection for non-invasive lung cancer diagnosis | NIH | National Cancer Institute | 2021 to 2023 | $712,147 | August 6, 2018 | July 31, 2024 | ZHENG, SIYANG | reporter.nih.gov |
| Statistical methods and tools for cancer risk prediction in families with germline mutations in TP53 | NIH | National Cancer Institute | 2021 to 2022 | $710,211 | April 1, 2019 | March 31, 2024 | WANG, WENYI | reporter.nih.gov |
| Rare Genetic Risk and Gene Networks in Tauopathy | NIH | National Institute on Aging | 2021 to 2024 | $709,776 | September 15, 2020 | May 31, 2025 | CHANG, TIMOTHY S | reporter.nih.gov |
| Machine-Assisted Interdisciplinary Approach For Early Clinical Evaluation of Neurodevelopmental Disorders | NIH | National Center for Advancing Translational Sciences | 2022 to 2023 | $706,039 | February 1, 2022 | January 31, 2025 | GROPMAN, ANDREA LYNNE | reporter.nih.gov |
| Family RESPOND: Defining the Genetic Basis of Prostate Cancer Risk in African American Families | NIH | National Cancer Institute | 2025 | $704,882 | April 1, 2025 | March 31, 2030 | HAIMAN, CHRISTOPHER ALAN | reporter.nih.gov |
| Navigating Ethical Frontiers of AI-Driven Clinical Decision Support Systems: Exploring Explainability and Bias | NIH | National Institute of Biomedical Imaging and Bioengineering | 2023 to 2024 | $699,143 | August 1, 2023 | July 31, 2026 | IQUEBAL, ASHIF | reporter.nih.gov |
| Modeling Precision Interventions for Prostate Cancer Control | NIH | National Cancer Institute | 2021 | $698,320 | September 10, 2020 | March 31, 2022 | ETZIONI, RUTH D | reporter.nih.gov |
| Multilevel investigation of uncertain and reclassified genomic variants in clinical oncology | NIH | National Cancer Institute | 2022 to 2024 | $692,993 | March 1, 2021 | August 31, 2025 | MAKHNOON, SUKH | reporter.nih.gov |
| Family Centered Approaches to Promoting Cascade Screening for Hereditary Cancer Syndromes among African Americans | NIH | National Cancer Institute | 2022 to 2025 | $691,200 | September 21, 2022 | August 31, 2027 | ELLIS, KATRINA RENEE | reporter.nih.gov |
| Integrative Analyses of Clinical Pharmacogenetic Data to Prevent Hospital Readmission in Real-World Health Systems | NIH | National Human Genome Research Institute | 2024 to 2025 | $687,963 | February 15, 2024 | January 31, 2027 | DAVID, SEAN P. | reporter.nih.gov |
| Rapid Acute Leukemia Genomic Profiling with CRISPR enrichment and Real-time long-read sequencing | NIH | National Cancer Institute | 2023 to 2024 | $687,444 | April 1, 2023 | March 31, 2026 | YEUNG, CECILIA C | reporter.nih.gov |
| Electronic health record (EHR)-based implementation strategies and decision support for hereditary breast and ovarian cancer (HBOC) genetic testing among multiethnic women (ELISABETH) | NIH | National Cancer Institute | 2025 | $686,993 | March 1, 2025 | February 28, 2027 | CREW, KATHERINE D | reporter.nih.gov |
| Development of recommendations and policies for genetic variant reclassification | NIH | National Human Genome Research Institute | 2021 | $682,898 | September 24, 2018 | June 30, 2023 | CHUNG, WENDY K | reporter.nih.gov |
| An Innovative Unbound Bilirubin Assay to Identify Bilirubin-Induced Neurological Dysfunction (BIND) Risk as Part of a Comprehensive and Novel Point-of-Care Newborn Screening Panel | NIH | National Heart, Lung, and Blood Institute | 2021 | $681,054 | July 1, 2019 | March 31, 2023 | ELDERBROOM, JENNIFER | reporter.nih.gov |
| Cell-free DNA fragmentomics as prognostic and treatment resistance biomarkers in metastatic castration-resistant prostate cancer | NIH | National Cancer Institute | 2025 | $680,453 | January 1, 2025 | December 31, 2029 | ZHAO, SHUANG | reporter.nih.gov |
| Molecular subtyping of brain tumors using a blood-based multiplexed assay | NIH | National Cancer Institute | 2025 | $678,228 | April 3, 2025 | March 31, 2030 | BALAJ, LEONORA | reporter.nih.gov |
| Neurodevelopmental Outcomes for CMV Infections Identified by Newborn Screening | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $676,561 | August 11, 2025 | July 31, 2030 | SWANSON, MEGHAN RAE | reporter.nih.gov |
| Precision Assessment and Delivery of Cancer Risks in BRCA 1/2 Mutation Cancers | NIH | National Cancer Institute | 2021 | $676,046 | September 18, 2017 | August 31, 2023 | REBBECK, TIMOTHY R | reporter.nih.gov |
| Using electronic medical record data to shorten diagnostic odysseys for rare genetic disorders in children and adults in two New York City health care settings | NIH | National Center for Advancing Translational Sciences | 2022 to 2023 | $676,000 | February 1, 2022 | January 31, 2024 | GELB, BRUCE D | reporter.nih.gov |
| Clinical Expansion of Precision Medicine in the Emergency Department | NIH | National Human Genome Research Institute | 2024 | $672,525 | September 23, 2024 | June 30, 2029 | DUARTE, JULIO DAVID | reporter.nih.gov |
| Genome-first approach to treatable genetic conditions in adults | NIH | National Human Genome Research Institute | 2023 to 2025 | $672,502 | January 2, 2023 | March 31, 2028 | GOLD, NINA BETH | reporter.nih.gov |
| The Burden of Genetic Disorders in Infant Mortality | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $672,020 | September 7, 2020 | August 31, 2025 | WOJCIK, MONICA HSIUNG | reporter.nih.gov |
| Transforming health at the intersection of implementation science, learning health systems, and genomics at Northwestern Medicine | NIH | National Human Genome Research Institute | 2024 | $666,062 | September 23, 2024 | July 31, 2029 | FRANKLIN, PATRICIA D | reporter.nih.gov |
| Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age | NIH | National Cancer Institute | 2025 | $663,923 | July 1, 2021 | June 30, 2027 | HITCHINS, MEGAN P | reporter.nih.gov |
| Proactive Outreach and Streamlined Genetic Testing in Prostate Cancer Survivors | NIH | National Cancer Institute | 2025 | $663,383 | August 1, 2025 | July 31, 2030 | SCHWARTZ, MARC D | reporter.nih.gov |
| The BRCA Exchange Knowledgebase for Clinical Cancer Genetics | NIH | National Cancer Institute | 2025 | $660,079 | September 1, 2025 | August 31, 2030 | CLINE, MELISSA SUZANNE | reporter.nih.gov |
| Implementing a genomics-enabled Learning Health System across Indiana | NIH | National Human Genome Research Institute | 2024 | $658,448 | September 23, 2024 | July 31, 2029 | SKAAR, TODD C. | reporter.nih.gov |
| Genetic Predictors of Early Clinical Failure in Diffuse Large B Cell Lymphoma | NIH | National Cancer Institute | 2021 | $657,422 | August 1, 2017 | January 31, 2023 | NOVAK, ANNE JOSEPHINE | reporter.nih.gov |
| Improving Management of patients at High Risk of Pancreatic Cancer | NIH | National Cancer Institute | 2025 | $653,819 | February 24, 2025 | January 31, 2030 | KLEIN, ALISON P | reporter.nih.gov |
| Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer | NIH | National Cancer Institute | 2021 | $652,359 | September 14, 2018 | August 31, 2023 | MISHRA, LOPA | reporter.nih.gov |
| An Integrative Radiogenomic Approach to Design Genetically-Informed Image Biomarker for Characterizing COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $650,726 | May 1, 2018 | December 31, 2022 | BATMANGHELICH, KAYHAN | reporter.nih.gov |
| Toward DNA Sequencing as a Primary Newborn Screen for Treatable Disorders not Amenable to Current Screening | NIH | National Human Genome Research Institute | 2021 to 2022 | $646,000 | July 1, 2021 | June 30, 2025 | RISCH, NEIL J. | reporter.nih.gov |
| Impact of Anticholinergic Medication on Salivary Function; Exploring Potential Genetic Markers for Dry Mouth | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $638,095 | July 13, 2021 | June 30, 2026 | ARANY, SZILVIA | reporter.nih.gov |
| Genetic Risk Underlying Pediatric Critical Illness | NIH | National Human Genome Research Institute | 2023 to 2025 | $633,198 | September 22, 2023 | January 2, 2026 | MOTELOW, JOSHUA ETHAN | reporter.nih.gov |
| AI-assisted quantitative photon-counting-detector CT imaging for cytogenetic risk prediction and treatment response in multiple myeloma | NIH | National Institute of Biomedical Imaging and Bioengineering | 2025 | $624,998 | April 1, 2025 | January 31, 2029 | BAFFOUR, FRANCIS | reporter.nih.gov |
| Pathogenesis of PCD Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 | $619,179 | January 1, 2004 | April 30, 2023 | KNOWLES, MICHAEL R | reporter.nih.gov |
| Virtual Platforms for Genetics Evaluation in the Medically Underserved | NIH | National Center for Advancing Translational Sciences | 2022 to 2023 | $619,000 | February 1, 2022 | January 31, 2024 | LALANI, SEEMA R | reporter.nih.gov |
| Comparative Effectiveness of Interventions to Increase Guideline-based Genetic Counseling in Ethnically and Geographically Diverse Cancer Survivors | NIH | National Cancer Institute | 2021 | $618,436 | December 22, 2016 | November 30, 2023 | KINNEY, ANITA Y. | reporter.nih.gov |
| Improving response prediction to neoadjuvant therapy in pancreatic cancer | NIH | National Cancer Institute | 2023 to 2025 | $605,166 | September 15, 2023 | October 1, 2025 | SINGH, HARSHABAD | reporter.nih.gov |
| Integrated Clinical-Grade genomic and pathology AI biomarkers for high-risk prostate cancer | NIH | National Cancer Institute | 2025 | $603,981 | August 18, 2025 | July 31, 2030 | ZHAO, SHUANG | reporter.nih.gov |
| Mobile Diagnosis of Congenital Genetic Conditions: A Model for Screening and Surveillance in Low-Resource Settings | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $601,018 | February 1, 2024 | January 31, 2027 | VILAIN, ERIC J. | reporter.nih.gov |
| Development of 5hmC and 5mC biomarkers in cell-free circulating DNA for sensitive colon cancer detection and prognosis | NIH | National Cancer Institute | 2021 | $599,788 | August 1, 2017 | July 31, 2023 | BISSONNETTE, BRUCE MARC | reporter.nih.gov |
| A reference-free computational algorithm for comprehensive somatic mosaic mutation detection | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $599,608 | April 1, 2023 | March 31, 2028 | MARTH, GABOR T | reporter.nih.gov |
| Breast Pre-Cancer Atlas Center | NIH | National Cancer Institute | 2021 to 2023 | $598,879 | April 4, 2023 | August 31, 2024 | HWANG, E.SHELLEY | reporter.nih.gov |
| Eliminating variants of uncertain significance in BRCA1, BRCA2 and beyond | NIH | National Cancer Institute | 2021 | $594,699 | September 1, 2019 | August 31, 2023 | CLINE, MELISSA SUZANNE | reporter.nih.gov |
| Advancing equitable implementation of genomic medicine in nephrology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $592,203 | September 15, 2022 | August 31, 2027 | MILO RASOULY, HILA | reporter.nih.gov |
| Piloting a standardized psychosocial assessment tool (BATHE) in genetic counseling | NIH | National Human Genome Research Institute | 2022 to 2024 | $590,250 | August 12, 2022 | May 31, 2026 | CAMPION, MARYANN W | reporter.nih.gov |
| Non-Invasive Fetal Sequencing (NIFS) as a Transformative Prenatal Genetic Screening Test | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $584,317 | September 1, 2025 | May 31, 2030 | TALKOWSKI, MICHAEL E | reporter.nih.gov |
| Common and rare sequence variants in breast cancer risk | NIH | National Cancer Institute | 2021 | $583,065 | September 30, 2007 | February 28, 2023 | TAVTIGIAN, SEAN VAHRAM | reporter.nih.gov |
| Improving the Precision of Genetic Markers for Psychotic Disorders | NIH | National Institute of Mental Health | 2021 to 2023 | $581,072 | March 5, 2020 | October 31, 2024 | JONAS, KATHERINE G | reporter.nih.gov |
| Programa de ARBOLES Familiares: Assessing Risk of Breast Cancer through Outreach to Latinas with Education and Support | NIH | National Cancer Institute | 2021 to 2022 | $580,282 | August 1, 2017 | November 30, 2023 | GRAVES, KRISTI D. | reporter.nih.gov |
| Perioperative Targeted Genotyping in Glioma | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $579,894 | April 15, 2019 | February 29, 2024 | SHANKAR, GANESH | reporter.nih.gov |
| Predicting individual disease risk for individuals harboring monogenic risk alleles with deep learning | NIH | National Human Genome Research Institute | 2025 | $579,403 | April 8, 2025 | February 28, 2030 | JORDAN, DANIEL MICHAEL | reporter.nih.gov |
| The role of early educational contexts in differential genetic susceptibility to cognitive impairment and dementia | NIH | National Institute on Aging | 2022 to 2025 | $579,020 | August 1, 2022 | July 31, 2027 | WALSEMANN, KATRINA | reporter.nih.gov |
| Let's Talk: Overcoming barriers to the uptake of cascade screening through a stakeholder-informed online intervention | NIH | National Human Genome Research Institute | 2024 | $575,098 | September 20, 2024 | August 31, 2026 | ROBERTS, MEGAN C. | reporter.nih.gov |
| Neurofibromatosis and Schwannomatosis Genes Variant Curation Expert Panel (VCEP) | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $574,838 | June 1, 2024 | May 31, 2027 | PLOTKIN, SCOTT R | reporter.nih.gov |
| Investigating personalized approaches to de-intensify therapy for nodular lymphocyte-predominant Hodgkin lymphoma | NIH | National Cancer Institute | 2024 to 2025 | $569,568 | August 1, 2024 | July 31, 2029 | BINKLEY, MICHAEL S | reporter.nih.gov |
| Pleiotropy in LMNA-associated Arrhythmogenic Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2022 | $568,552 | September 22, 2022 | August 31, 2024 | MCDONALD, THOMAS V | reporter.nih.gov |
| Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations | NIH | National Cancer Institute | 2022 to 2024 | $568,121 | August 8, 2022 | July 31, 2025 | SALIPANTE, STEPHEN J | reporter.nih.gov |
| Health care system-led familial risk notification: design and ethical assessment | NIH | National Human Genome Research Institute | 2021 to 2023 | $559,616 | September 20, 2018 | June 30, 2024 | BLASI, PAULA RAE | reporter.nih.gov |
| Molecular Sub-typing Breast Cancer Patients using a Liquid Biopsy | NIH | National Cancer Institute | 2022 to 2024 | $557,912 | September 1, 2022 | August 31, 2025 | SOPER, STEVEN ALLAN | reporter.nih.gov |
| Bundled Multicancer Screening and Genetic Services Navigation to Improve Cancer Outcomes | NIH | National Cancer Institute | 2025 | $547,047 | May 1, 2025 | April 30, 2030 | O'NEILL, SUZANNE C. | reporter.nih.gov |
| Precision Genomic Medicine in The Plain Communities and its Impact on The Plain and General Population | NIH | National Human Genome Research Institute | 2021 to 2023 | $546,216 | September 12, 2019 | June 30, 2024 | GHALOUL-GONZALEZ, LINA | reporter.nih.gov |
| Developing Consensus on a Practical Framework for Variant Reclassification and Recontact | NIH | National Cancer Institute | 2025 | $541,972 | January 1, 2025 | December 31, 2029 | MAKHNOON, SUKH | reporter.nih.gov |
| Novel imaging genetic biomarkers for sporadic frontotemporal dementia through machine learning | NIH | National Institute on Aging | 2021 to 2025 | $527,986 | March 15, 2021 | February 28, 2026 | BROCE-DIAZ, IRIS J | reporter.nih.gov |
| Sex-Specific Psychosis Biotypes: Informed Data-driven Neurobiological and Genomic Markers for Early Risk Detection | NIH | National Institute of Mental Health | 2025 | $525,048 | December 13, 2024 | October 31, 2028 | IRAJI, ARMIN | reporter.nih.gov |
| Transcriptional Responses to Wildfire Pollution in Airway Epithelial Cells Identify Genetic Risk Factors and Mechanisms of Asthma Exacerbations | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $522,504 | December 17, 2022 | November 30, 2027 | GUPTA, ARNAV | reporter.nih.gov |
| Evaluating the Risks and Benefits of the Next Generation of Direct-to-Consumer Genetic Tests | NIH | National Human Genome Research Institute | 2021 to 2023 | $519,679 | September 1, 2020 | August 31, 2025 | KILBRIDE, MADISON K | reporter.nih.gov |
| Integrating Nurse Champion Model for Group Reproductive Genetic Counseling forSickle Cell Hemoglobinopathies into Primary Care: A Pilot Implementation ScienceStudy | NIH | National Human Genome Research Institute | 2021 to 2023 | $516,327 | March 15, 2022 | June 30, 2025 | JAJA, CHEEDY | reporter.nih.gov |
| Validation and implementation of ctDNA as a clinically informative biomarkerin AYAs with sarcomas. | NIH | National Cancer Institute | 2024 to 2025 | $506,847 | August 1, 2024 | July 31, 2029 | SHULMAN, DAVID | reporter.nih.gov |
| Managing the Uncertainty of Genetic Information in Neonates | NIH | National Human Genome Research Institute | 2023 to 2025 | $500,961 | July 14, 2023 | May 31, 2028 | CALLAHAN, KATHARINE PRESS | reporter.nih.gov |
| The Genetic Basis of Morbidity and Mortality in Small for Gestational Age Preterm Infants | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $499,597 | September 19, 2023 | August 31, 2028 | HAYS, THOMAS | reporter.nih.gov |
| Uncovering compensatory mechanisms in family members with disease causing mutations of pulmonary hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $498,000 | August 15, 2020 | July 31, 2023 | GU, MINGXIA | reporter.nih.gov |
| Placental Transcriptomics and Risk for Schizophrenia | NIH | National Institute of Mental Health | 2021 to 2022 | $497,750 | December 24, 2020 | November 30, 2023 | URSINI, GIANLUCA | reporter.nih.gov |
| Promoting Genetic Counselors in Independent Research Through Advanced Training and Education (PROMOTE-GC) | NIH | National Human Genome Research Institute | 2024 to 2025 | $494,976 | August 5, 2024 | July 31, 2029 | RASMUSSEN, SONJA ANN | reporter.nih.gov |
| Unrecognized scale and clinical relevance of somatic mosaicism | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $494,398 | September 13, 2017 | June 30, 2022 | STANKIEWICZ, PAWEL | reporter.nih.gov |
| Promoting Genetic Counseling among African American Women with Hereditary Risk for Breast Cancer | NIH | National Cancer Institute | 2022 to 2024 | $488,554 | October 16, 2021 | May 31, 2025 | HENDERSON, VIDA ANN | reporter.nih.gov |
| Understanding Disparities in Genomic Medicine | NIH | National Human Genome Research Institute | 2022 to 2023 | $486,750 | July 1, 2022 | December 31, 2024 | WOJCIK, MONICA HSIUNG | reporter.nih.gov |
| Dried blood spot proteomics analysis of newborn screening cards to identify prognostic markers of SIDS risk | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $486,750 | August 1, 2023 | July 31, 2025 | HAYNES, ROBIN LYNN | reporter.nih.gov |
| Proteomic, Genomic, and Longitudinal Pathways to Ovarian Cancer Biomarker Discovery | NIH | National Cancer Institute | 2021 | $483,194 | April 1, 2021 | March 31, 2024 | SKATES, STEVEN J | reporter.nih.gov |
| Development of Family1st-An interactive web-based tool with evidence-based approaches to communicate hereditary cancer risk to at risk relatives and promote cascade testing. | NIH | National Cancer Institute | 2022 | $476,880 | September 19, 2022 | August 31, 2025 | GRAY, STACY W. | reporter.nih.gov |
| Clinical and genetic studies of hereditary neurological disorders in Mali | NIH | National Human Genome Research Institute | 2021 to 2022 | $463,441 | June 1, 2022 | June 30, 2023 | LANDOURE, GUIDA | reporter.nih.gov |
| A new diagnostic tool for rapid detection and characterization of REPEAT SEQUENCES in inherited diseases | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $459,016 | August 15, 2022 | December 31, 2024 | REED, JASON C | reporter.nih.gov |
| Development of a surrogate liquid biopsy from the aqueous humor in retinoblastoma eyes. | NIH | National Cancer Institute | 2021 to 2022 | $457,516 | August 1, 2018 | July 31, 2023 | BERRY, JESSE L | reporter.nih.gov |
| Implementing Pharmacogenomics in Diverse Health Care Systems | NIH | National Human Genome Research Institute | 2021 | $455,085 | September 22, 2021 | August 31, 2024 | SPERBER, NINA | reporter.nih.gov |
| Cell-free DNA-Based Analysis for Diagnosis, Monitoring and Optimization of Therapy for Patients with Primary Central Nervous System Lymphomas | NIH | National Center for Advancing Translational Sciences | 2022 to 2023 | $450,312 | September 15, 2022 | July 31, 2025 | BETTEGOWDA, CHETAN | reporter.nih.gov |
| Defining the molecular mechanisms of COPA syndrome through computational modeling and functional studies | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $447,875 | April 8, 2021 | March 31, 2023 | SHUM, ANTHONY | reporter.nih.gov |
| Exploring the Genomic Dark Matter of Neurodevelopmental Disorders | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $446,875 | May 1, 2022 | August 31, 2024 | SCHRAUWEN, ISABELLE VEERLE SUZANNE | reporter.nih.gov |
| Comprehensive Pediatric Phenotyping for Evidence-Based Diagnosis in Genetic Disease | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $446,472 | June 1, 2023 | May 31, 2028 | CAMPBELL, IAN MORGAN | reporter.nih.gov |
| GenePAL: A Portable Approach to Longitudinal Genomic Healthcare for Infants | NIH | National Human Genome Research Institute | 2025 | $446,042 | January 1, 2025 | December 31, 2026 | WOJCIK, MONICA HSIUNG | reporter.nih.gov |
| Multi-cancer Early Detection | NIH | National Cancer Institute | 2025 | $445,446 | April 8, 2018 | March 31, 2030 | KISIEL, JOHN | reporter.nih.gov |
| Long-read strategies for elucidating transcriptome complexity and advancing genomic medicine | NIH | National Institute of General Medical Sciences | 2025 | $445,000 | June 1, 2025 | April 30, 2030 | LIN, LAN | reporter.nih.gov |
| Molecular biomarkers of future aggressive behavior in pituitary tumors | NIH | National Cancer Institute | 2023 to 2024 | $444,768 | April 15, 2023 | March 31, 2026 | LIN, ANDREW | reporter.nih.gov |
| Genetic and transcriptomic profiling of the epileptic network in patients with surgically treated seizures | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $444,125 | July 15, 2022 | June 30, 2025 | PAREDES, MERCEDES | reporter.nih.gov |
| A new human iPSC model of ALS: natural modifiers protecting FUS mutation carriers from the disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $443,750 | July 1, 2021 | December 31, 2023 | GUO, ZIYUAN | reporter.nih.gov |
| NeoGx-III: Interpretable Machine Learning with Integrated Analysis of Maternal & Infant Electronic Medical Records for Unbiased Prediction of Need for Genome Sequencing in Level III NICUs | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $434,500 | August 1, 2025 | July 31, 2027 | CHAUDHARI, BIMAL PANKAJ | reporter.nih.gov |
| Genetic predisposition and misdiagnosis of cancer in All of Us participants | NIH | National Cancer Institute | 2024 | $434,379 | July 15, 2024 | June 30, 2027 | BAILEY, MATTHEW H | reporter.nih.gov |
| Genetic Mosaicism in Inborn Errors of Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $433,125 | February 3, 2022 | January 31, 2025 | COOPER, MEGAN ANNE | reporter.nih.gov |
| Development and Initial Testing of a Behavioral Intervention to Increase Pre-Test Genetic Counseling Among Families at Risk of Lynch Syndrome | NIH | National Cancer Institute | 2024 to 2025 | $429,699 | February 1, 2023 | August 31, 2027 | YAN, HAOYANG | reporter.nih.gov |
| Improving Prediction of Prognosis in Frontotemporal Dementia Using Epigenetic and Genetic Markers of Biological Aging and Disease | NIH | National Institute on Aging | 2021 | $429,000 | June 1, 2021 | May 31, 2024 | OPHOFF, ROEL A | reporter.nih.gov |
| Newborn screening and treatment monitoring for patients with pyridoxine-dependent epilepsy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $427,625 | June 8, 2022 | May 31, 2025 | COUGHLIN, CURTIS R | reporter.nih.gov |
| Scaling Strategies to Assess Pathogenicity of Variants of Uncertain Significance | NIH | National Eye Institute | 2025 | $427,625 | September 30, 2025 | September 29, 2027 | BALDRIDGE, DUSTIN M | reporter.nih.gov |
| Biochemical and Molecular Newborn Screening for Familial Hypercholesterolemia | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $427,542 | May 1, 2021 | April 30, 2024 | PETERSON, AMY LH | reporter.nih.gov |
| Disparities in the effect of state policy for the newborn screening for critical congenital heart diseases | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $423,775 | September 23, 2021 | August 31, 2024 | SAKAI-BIZMARK, RIE | reporter.nih.gov |
| A Phase 2 Study of the Value of Pre-symptomatic Genetic Risk Assessment for Age-Related Macular Degeneration | NIH | National Eye Institute | 2022 to 2023 | $422,646 | May 1, 2022 | April 30, 2025 | BERNSTEIN, PAUL STEVEN | reporter.nih.gov |
| Implementing and Evaluating Genetic Screening in Healthy Adults for Precision Public Health | NIH | National Human Genome Research Institute | 2022 | $420,769 | September 1, 2022 | August 31, 2024 | ROBERTS, MEGAN C. | reporter.nih.gov |
| Error-suppressed whole genome sequencing for genotoxicant-induced structural variant detection | NIH | National Institute of Environmental Health Sciences | 2023 | $418,413 | July 14, 2023 | June 30, 2026 | WILSON, THOMAS EDWARD | reporter.nih.gov |
| Defining the phenotype and cancer penetrance of CTNNA1 loss-of-function germline variants | NIH | National Cancer Institute | 2023 to 2024 | $416,922 | December 15, 2022 | November 30, 2024 | KATONA, BRYSON WILLIAM | reporter.nih.gov |
| Screening for Cardiac Amyloidosis with a Blood Biomarker in Minority Populations – SCABB-MP | NIH | National Heart, Lung, and Blood Institute | 2025 | $416,849 | July 15, 2025 | May 31, 2029 | SAELICES GOMEZ, LORENA | reporter.nih.gov |
| Biomarkers for Early Detection of Colorectal Cancer in Ulcerative Colitis | NIH | National Cancer Institute | 2021 to 2022 | $415,805 | June 19, 2017 | May 31, 2024 | CHEN, RU | reporter.nih.gov |
| Optimal newborn screening algorithms - efficacy and equity | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $409,750 | September 10, 2024 | August 31, 2027 | BISH, DOUGLAS | reporter.nih.gov |
| Mobile Diagnosis of Congenital Genetic Conditions: A Model for Screening and Surveillance in Low-Resource Settings | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $409,475 | September 1, 2021 | January 31, 2024 | LINGURARU, MARIUS GEORGE | reporter.nih.gov |
| Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus | NIH | National Cancer Institute | 2021 | $407,598 | August 25, 2010 | September 30, 2022 | MARKOWITZ, SANFORD D. | reporter.nih.gov |
| Development of a Urine Genetic Test for NonMuscle Invasive Bladder Cancer | NIH | National Human Genome Research Institute | 2023 | $406,500 | August 1, 2023 | July 31, 2025 | LIN, SELENA | reporter.nih.gov |
| HLA LOH Detection via Liquid Biopsy: A Blood-Based Predictive Biomarker Assay for Precision Immuno-Oncology | NIH | National Cancer Institute | 2025 | $406,500 | September 12, 2025 | August 31, 2027 | SINKOE, ANDREW | reporter.nih.gov |
| Genetic Mechanisms of Amelogenesis Imperfecta | NIH | National Institute of Dental & Craniofacial Research | 2021 | $402,467 | September 1, 2021 | August 31, 2023 | HU, JAN CHING CHUN | reporter.nih.gov |
| Leveraging Large Language Models to Enhance Regional Genomic Medicine eConsults | NIH | National Human Genome Research Institute | 2025 | $400,618 | September 20, 2025 | August 31, 2026 | ISENSTEIN, HOWARD | reporter.nih.gov |
| Microsatellite Instability Sequencing via Single-Molecule DNA Re-Reading | NIH | National Cancer Institute | 2023 | $400,000 | September 18, 2023 | March 31, 2025 | SCHIBEL, ANNA | reporter.nih.gov |
| Accurate prognosis and prediction of clinical benefits of adjuvant therapy for early-stage non-small cell lung cancer | NIH | National Cancer Institute | 2024 | $400,000 | April 1, 2024 | March 31, 2026 | YE, QING | reporter.nih.gov |
| Development of a biomarker panel for screening and early detection of gynecological cancers | NIH | National Cancer Institute | 2021 | $399,972 | September 1, 2021 | August 31, 2023 | MARTIGNETTI, JOHN A | reporter.nih.gov |
| Novel Sequencing Based Diagnostics for Leukemia in Low Resource Settings | NIH | National Cancer Institute | 2022 to 2023 | $399,830 | July 1, 2022 | June 30, 2025 | ALEXANDER, THOMAS BLICK | reporter.nih.gov |
| A novel ctDNA analysis solution for the next-generation of liquid biopsy assays | NIH | National Cancer Institute | 2025 | $399,816 | September 1, 2025 | August 31, 2026 | MIR, KALIM ULLAH | reporter.nih.gov |
| Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options | NIH | National Human Genome Research Institute | 2023 | $399,810 | September 18, 2023 | March 31, 2024 | SCHERER, ANDREAS | reporter.nih.gov |
| Ultra-precision diagnostics for ALK+ non-small cell lung cancer | NIH | National Cancer Institute | 2025 | $399,153 | July 9, 2025 | June 30, 2027 | ARMANT, DAVID RANDALL | reporter.nih.gov |
| Development of a highly sensitive DNA hypermethylation-based kit to identify Barrett's esophagus patients at high risk of progressing to esophageal adenocarcinoma | NIH | National Cancer Institute | 2024 | $398,738 | September 4, 2024 | August 31, 2025 | ZHOU, ZHONGREN | reporter.nih.gov |
| High-throughput functional analysis and clinical relevance of all possible variants of a gene | NIH | National Human Genome Research Institute | 2023 | $398,526 | February 2, 2023 | January 31, 2025 | SCHILLER, MARTIN R. | reporter.nih.gov |
| Improving Family Cancer History Collection using Social Network, Human Centered Design, and Implementation Science Approaches | NIH | National Cancer Institute | 2021 to 2024 | $396,174 | June 1, 2021 | September 4, 2024 | ALLEN, CAITLIN GLOECKNER | reporter.nih.gov |
| A DNA Methylation Test for Guiding Lung Cancer Screening | NIH | National Cancer Institute | 2021 | $395,569 | September 1, 2021 | August 31, 2022 | PHILIBERT, ROBERT A | reporter.nih.gov |
| Exploiting Urine Derived DNA for the Assessment of Bladder Cancer using High Accuracy Sequencing | NIH | National Cancer Institute | 2021 to 2022 | $395,468 | April 1, 2021 | March 31, 2024 | KENNEDY, SCOTT ROBERT | reporter.nih.gov |
| Efficient and cost-effective breast cancer risk stratification using whole slide histopathology images | NIH | National Cancer Institute | 2023 to 2024 | $394,314 | April 6, 2023 | March 31, 2026 | GURCAN, METIN NAFI | reporter.nih.gov |
| Novel ultra-short cell free DNA biomarkers for early detection of non-small cell lung cancer. | NIH | National Cancer Institute | 2023 to 2024 | $393,344 | July 15, 2023 | June 30, 2026 | LI, FENG | reporter.nih.gov |
| A multimodal approach to develop molecular markers to predict response to immune targeted agents in non-small cell lung cancer | NIH | National Cancer Institute | 2021 to 2022 | $392,828 | September 17, 2018 | February 29, 2024 | THOMPSON, JEFFREY C | reporter.nih.gov |
| DNA methylation, Liquid Biopsy, and Pancreatic Cancer | NIH | National Cancer Institute | 2022 to 2023 | $391,100 | April 7, 2022 | December 31, 2024 | NELSON, MARK ANTHONY | reporter.nih.gov |
| Whole Genome Sequencing for Genomic Evaluation and Risk Stratification of Patients with Myelodysplastic Syndromes | NIH | National Cancer Institute | 2025 | $388,750 | September 15, 2022 | August 31, 2028 | DUNCAVAGE, ERIC J | reporter.nih.gov |
| Validating the performance and inclusivity of a novel functionally-informed predictive genetic test method for polygenic disease | NIH | National Human Genome Research Institute | 2023 | $387,472 | August 3, 2023 | July 31, 2024 | PATWARDHAN, TEJAL | reporter.nih.gov |
| Latinas CaPACES: Connecting and Promoting Active Cancer Engagement Successfully using a Culturally-Tailored Digital Tool to Reduce Delays in Breast Cancer Diagnostic Follow-up Testing and Treatment | NIH | National Cancer Institute | 2022 | $387,235 | September 14, 2022 | August 31, 2024 | HAACKE, CARL | reporter.nih.gov |
| Previvors Recharge: A Resilience Program for Cancer Previvors | NIH | National Cancer Institute | 2023 to 2024 | $386,615 | May 1, 2023 | April 30, 2025 | EVERS, KERRY | reporter.nih.gov |
| Piloting an Implementation Strategy for Mainstream Genetic Testing in Colorectal Cancer | NIH | National Cancer Institute | 2024 to 2025 | $384,866 | September 1, 2024 | August 31, 2029 | HOLLIS, ROBERT H | reporter.nih.gov |
| CRISPR-based depletion method for resolving pseudogene contamination in Next Generation Sequencing (NGS) based genetic testing | NIH | National Human Genome Research Institute | 2025 | $383,748 | March 3, 2025 | February 28, 2027 | BROWN, KEITH | reporter.nih.gov |
| Elucidating Cancer Risk in BRCA2 and RAD51 Variants | NIH | National Cancer Institute | 2021 | $383,156 | April 1, 2017 | March 31, 2023 | JENSEN, RYAN BROWN | reporter.nih.gov |
| Circulating DNA methylation biomarkers in micrometastatic breast cancer | NIH | National Cancer Institute | 2021 | $380,678 | September 15, 2017 | August 31, 2023 | SALHIA, BODOUR | reporter.nih.gov |
| Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer using Pathology Biopsies | NIH | National Cancer Institute | 2021 | $378,398 | April 1, 2020 | March 31, 2023 | COOKS, ROBERT GRAHAM | reporter.nih.gov |
| Genetic and MRI biomarkers of neuroplasticity predict aphasia recovery and phenotypes | NIH | National Institute on Deafness and Other Communication Disorders | 2024 to 2025 | $375,122 | June 1, 2024 | May 31, 2029 | DRESANG, HALEY C. | reporter.nih.gov |
| Development of diagnostic and prognostic tests for esophageal adenocarcinoma | NIH | National Cancer Institute | 2021 to 2022 | $374,895 | December 16, 2016 | November 30, 2023 | GODFREY, TONY E | reporter.nih.gov |
| Language as a Candidate Marker of FXTAS in FMR1 Premutation Carriers | NIH | National Institute on Deafness and Other Communication Disorders | 2023 to 2024 | $373,437 | September 16, 2022 | July 31, 2025 | MALTMAN, ALEXIS NELL | reporter.nih.gov |
| Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations and methylation | NIH | National Cancer Institute | 2025 | $369,468 | September 1, 2025 | August 31, 2028 | SALIPANTE, STEPHEN J | reporter.nih.gov |
| Optimization of anal cancer screening for people with HIV using genomic methods | NIH | National Cancer Institute | 2024 to 2025 | $369,313 | September 1, 2024 | August 31, 2029 | SILVERA, RICHARD | reporter.nih.gov |
| Multi-omic liquid biopsy assessment in NCI trials: evaluating ctDNA, extravesicle RNA, and outcomes with immunotherapy in patient with colorectal and anal cancers | NIH | National Cancer Institute | 2024 to 2025 | $363,280 | September 12, 2024 | August 31, 2029 | MORRIS, VAN K | reporter.nih.gov |
| Expert curation of clinically significant variants in genes for early onset retinal degeneration | NIH | National Eye Institute | 2025 | $360,524 | September 15, 2025 | June 30, 2028 | AYYAGARI, RADHA | reporter.nih.gov |
| Identifying strategies to reveal genetic results over the lifespan | NIH | National Human Genome Research Institute | 2023 to 2024 | $359,640 | September 1, 2023 | August 31, 2025 | LEWIS, ANNA | reporter.nih.gov |
| Development of a Genetic Testing and Counseling for Pantothenate Kinase Associated Neurodegeneration in the Dominican Republic | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $357,767 | August 20, 2025 | August 19, 2027 | MAYEUX, RICHARD P | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Color Health, Inc. | Burlingame, CA | 2 | $60.9 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 19 | $50.9 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 18 | $44.3 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 20 | $32.8 million | 0 | $0 |
| Stanford University | Stanford, CA | 14 | $32.2 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 12 | $27.4 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 9 | $26.1 million | 0 | $0 |
| University of Washington | Seattle, WA | 12 | $25.2 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 13 | $21.4 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 15 | $21.2 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 17 | $20.9 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 11 | $20.9 million | 0 | $0 |
| Banner Health | Phoenix, AZ | 2 | $20.6 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 13 | $19.4 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 14 | $19.1 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 13 | $18.4 million | 0 | $0 |
| Geisinger Clinic | Danville, PA | 6 | $16.3 million | 0 | $0 |
| University of Chicago | Chicago, IL | 7 | $13.4 million | 0 | $0 |
| Duke University | Durham, NC | 9 | $13.1 million | 0 | $0 |
| Washington University | Saint Louis, MO | 15 | $12.6 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 7 | $12.4 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 6 | $12.2 million | 0 | $0 |
| Georgetown University | Washington, DC | 9 | $10.5 million | 0 | $0 |
| Ohio State University | Columbus, OH | 7 | $10 million | 0 | $0 |
| University of Florida | Gainesville, FL | 4 | $9.8 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 4 | $9.6 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 8 | $9.2 million | 0 | $0 |
| Dana-Farber Cancer Inst | Boston, MA | 8 | $9.1 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 10 | $9.1 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 5 | $8.9 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 7 | $8.7 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 6 | $8.4 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 10 | $8.1 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 2 | $7.9 million | 0 | $0 |
| Yale University | New Haven, CT | 5 | $7.7 million | 0 | $0 |
| Fred Hutchinson Cancer Center | Seattle, WA | 6 | $7.5 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 9 | $7.4 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 6 | $7.2 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 7 | $7 million | 0 | $0 |
| Children's Research Institute | Washington, DC | 6 | $6.8 million | 0 | $0 |
| Massachusetts Eye and Ear Infirmary | Boston, MA | 4 | $6.3 million | 0 | $0 |
| American College of Medical Genetics | Bethesda, MD | 1 | $6.2 million | 0 | $0 |
| H. Lee Moffitt Cancer CTR & Res Inst | Tampa, FL | 5 | $6.1 million | 0 | $0 |
| Kaiser Foundation Research Institute | Oakland, CA | 4 | $5.9 million | 0 | $0 |
| Health Research Incorporated/New York State Department of Health | Menands, NY | 1 | $5.9 million | 0 | $0 |
| Beckman Research Institute/city of Hope | Duarte, CA | 2 | $5.6 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 4 | $5.1 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 3 | $5 million | 0 | $0 |
| Loma Linda University | Loma Linda, CA | 2 | $4.9 million | 0 | $0 |
| Emory University | Atlanta, GA | 5 | $4.9 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 5 | $4.8 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 8 | $4.6 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 2 | $4.6 million | 0 | $0 |
| Pacific Northwest Research Institute | Seattle, WA | 2 | $4.4 million | 0 | $0 |
| Harvard Pilgrim Health Care, Inc. | Canton, MA | 2 | $4.3 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 3 | $4.1 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 3 | $3.9 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 2 | $3.8 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 1 | $3.7 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 3 | $3.7 million | 0 | $0 |
| Jackson Laboratory | Bar Harbor, ME | 1 | $3.6 million | 0 | $0 |
| Research Triangle Institute | Research Triangle Park, NC | 2 | $3.6 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 2 | $3.6 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 4 | $3.3 million | 0 | $0 |
| Tufts Medical Center | Boston, MA | 1 | $3.2 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 2 | $3.2 million | 0 | $0 |
| Morgan and Mendel Genomics, Inc. | Wilmington, DE | 2 | $3.2 million | 0 | $0 |
| ST. Jude Children's Research Hospital | Memphis, TN | 2 | $3.1 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 3 | $3.1 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 3 | $3 million | 0 | $0 |
| Oklahoma Medical Research Foundation | Oklahoma City, OK | 1 | $3 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 2 | $2.9 million | 0 | $0 |
| Baebies, Inc. | Durham, NC | 3 | $2.8 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 1 | $2.5 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 6 | $2.5 million | 0 | $0 |
| SUNY at Binghamton | Binghamton, NY | 1 | $2.4 million | 0 | $0 |
| Rutgers University New Brunswick | New Brunswick, NJ | 2 | $2.3 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 2 | $2.3 million | 0 | $0 |
| Carnegie Mellon University | Pittsburgh, PA | 2 | $2.2 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 1 | $2.1 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 2 | $2.1 million | 0 | $0 |
| Children's Hospital of Los Angeles | Los Angeles, CA | 2 | $2.1 million | 0 | $0 |
| Constantiam Biosciences Inc. | Katy, TX | 1 | $2 million | 0 | $0 |
| Isabl Inc. | New York, NY | 1 | $2 million | 0 | $0 |
| Engineering Resources Group, Inc. | Pembroke Pines, FL | 1 | $2 million | 0 | $0 |
| Region Hovedstaden | Hilleroed | 1 | $2 million | 0 | $0 |
| Binary Genomics, Inc. | Phoenix, AZ | 1 | $2 million | 0 | $0 |
| GLC Biotechnology, Inc. | Hudson, OH | 1 | $2 million | 0 | $0 |
| Spatial Genomics, Inc. | Pasadena, CA | 1 | $2 million | 0 | $0 |
| Cantata Bio LLC | Worcester, MA | 1 | $2 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 3 | $2 million | 0 | $0 |
| Frameshift Labs, Inc. | Cambridge, MA | 1 | $2 million | 0 | $0 |
| Sage Science, Inc. | Beverly, MA | 1 | $2 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 4 | $1.9 million | 0 | $0 |
| Inherent Biosciences, Inc. | Salt Lake City, UT | 1 | $1.9 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 3 | $1.8 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 1 | $1.8 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 3 | $1.8 million | 0 | $0 |
| Phase Genomics, Inc. | Seattle, WA | 1 | $1.7 million | 0 | $0 |
| Golden Helix, Inc. | Bozeman, MT | 2 | $1.7 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 294 | $205,426,371 | 0 | $0 |
| 2024 | 332 | $201,518,872 | 0 | $0 |
| 2023 | 329 | $200,576,563 | 0 | $0 |
| 2022 | 283 | $177,416,220 | 0 | $0 |
| 2021 | 279 | $166,747,328 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.